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ABSTRACT 
It is well known that obstructive sleep apnea and associated intermittent hypoxemia 
cause deficit in learning and memory in human. We had shown previously that 
intermittent hypoxia (IH) impairs long-term potentiation (LTP) in hippocampal CAl 
region of mice significantly, which may underlie the observed memory deficits in 
obstructive sleep apnea (OSA) models and patients. To investigate the possible 
mechanisms underlying such observation, we first examined the effect of 
intermittent hypoxia on the membrane properties and excitability of hippocampal 
CAl neurons by means of whole cell patch clamp. Intermittent hypoxia decreased 
the membrane input resistance in 14 days groups, without changing the membrane 
capacitance. Also, as revealed by the threshold of action potential firing and the 
input-output relationship, the excitability of the CAl neurons were found to be 
significantly reduced after intermittent hypoxia treatment. In addition, the action 
potentials generated by CAl neurons in both 7 days and 14 days IH groups 
exhibited changes in its waveform, as reflected by an increase in area, width of 
action potential and decrease in the rise and decay kinetics and after 
hyperpolarization. Changes in other active conductance including the rebound 
spikes and calcium spike were also found after intermittent hypoxia treatment. 
These data suggest that the electrophysiological properties of CAl neurons have 
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been compromised under longer term intermittent hypoxia treatment. 
We next studied the effect of IH on the expression of brain-derived neurotrophic 
factor (BDNF), which is known to play a critical role in LTP. The levels of the total 
BDNF, and also those of NT-3, NT-4/5 and nerve growth factor (NGF) in the 
hippocampi were determined by enzyme linked immunosorbent assay (ELISA). 
Significant decrease in total BDNF expression was found in both 7 days IH group 
and 14 days group IH, compared with the control group, while there was no 
significant change in the 3 days group. Similar trends were observed in the case of 
NGF while there was no significant change in the level of NT-4/5 and NT-3. It is 
known that IH decreased the expression of phosphorylated cAMP response element 
binding protein (CREB). Our results support the notion that CREB-dependent 
transcription of genes, including BDNF, is impaired in IH, and which may underlie 
the impaired LTP in intermittent hypoxia. Interestingly, we found that 7 days of IH 
treatment is sufficient to produce a delayed reduction in hippocampal BDNF 
expression. This effect is long-lasting and not recoverable within the time-frame 
tested, namely, up to 2 weeks. 
The effects of IH on different forms of BDNF were also studied. A significant 
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decrease in mature BDNF monomer was found in 3 days IH, 7 days and 14 days 
group. Similar trends were observed in mature BDNF dimmer, while there was no 
significant change in pro-BDNF in both groups. The cleavage of pro-BDNF to 
mature BDNF is mainly via the action of plasmin, which in turn is generated by 
tissure plasminogen activator (tPA), the enzyme responsible for cleavage of 
plasminogen to plasmin. To further elucidate the possible mechanism of reduced 
BDNF expression, the expression levels tPA, plasminogen and also that of plasmin 
were examined. The level of both tPA and plasmin were reduced, and was 
dependent on the days of IH treatment but the plasminogen level remained similar 
to that of control. These data suggest that the reduced expression of mature 
BDNF may underlie the observed impairment in hippocampal LTP, which in turn is 
due to reduced expression of the tPA/plasmin system in converting pro BDNF to 
mature BDNF. 
Overall, our results suggest that, in hippocampi CAl region, decreased cleavage of 
pro-to mature BDNF as a direct result of reduced tPA/plasmin system, or indirectly 
due to decreased excitability and activity of CAl neurons, or both, may underlie 
the observed deficit in BDNF-dependent LTP, and therefore reduced learning and 

















疫吸附測定（enzyme linked immunosorbent assay, ELISA)法，我們檢測了小鼠 
海馬體整體腦源性神經營養因數、神經營養因數-3 (Neurotrophin-3, N T - 3 ) � 





























CHAPTER 1 INTRODUCTION 
1.1 Obstructive sleep apnea Syndrome 
Obstructive sleep apnea (or hypoventilation) syndrome (OSAHS) in both children 
and adults is a cyclical hypoxia that is caused by the repetitive upper airway 
obstruction or central apnea (Mathieu et al.，2007). OSAHS may influence up to 
2% of children (Marcus, 2000; Roux et al., 2000) and 5% of the general population 
with at least 4% of males and 2% of females (Partinen et al., 1992; Redline et al.， 
1994; National Heart, Lung, Blood Institute Working Group on Sleep Apnea, 1996). 
The most distinct symptoms are episodes which are typically accompanied by 
oxyhemoglobin desaturation. They usually terminate itself by brief microarousals 
that outcome in sleep fragmentation and diminished amounts of slow wave and 
REM sleep (Deegan et al , 1995). During OSAHS, arterial O2 saturation has been 
reported to drop to very low levels (50-60%) with every cycle which may probably 
associated with substantial neurocognitive morbidity, particularly in children 
(Gozal et al., 2001; Row et al., 2002). In addition, periodic alveolar hypoventilation 
and repeated arousal either behavioral or electroencephalographic take place 
leading to sleep fragmentation and deprivation. This cyclical hypoxia, which 
generally happen throughout the night, can repeat itself tens to hundreds of times 
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itself in a single night which can vary in severity (Xiang et al.，2001). 
1.1.1 Symptoms of OSA 
The symptoms of OSA can be divided to nocturnal symptoms and daytime 
symptoms. During sleep, snoring is the signet symptom of sleep apnea which 
reflects the narrowing of the upper airway (Deegan et al., 1995). Snoring is the 
most frequent symptom of OSA, occurring in up to 95% of patients, but has poor 
predictive value because of the high prevalence in the general population (Flemons 
et al., 1994; Gottlieb et al., 2000). However, the absence of snoring makes OSA 
unlikely since only 6% of patients with OSA did not report snoring (Viner et al., 
1991). Meanwhile, witnessed apneas of breathing pauses by the bed partner are 
also a good diagnostic predictor of OSA but the severity of the disorder cannot be 
predicted from this (Hoffstein et al., 1993; Deegan et al., 1996). Nocturnal choking 
or gasping reflects an episode of outright wakening during obstructive sleep apnea. 
Sleep maintenance insomia is also often revealed as a symptom which reflects the 
disturbing effect on sleep of recurring arousal. Furthermore, nocturia, enuresis, 
frequent arousals, diaphoresis, and impotence may be reported by patients or their 
bed partner (Walter et al., 2008). There are also some symptoms that can be 
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observed in daytime. One of the important daytime symptoms of sleep apnea is 
excessive daytime sleepiness but it is not a clinical feature to discriminate between 
patient with and without disorder (Young et al., 1993; Young et al.，2002). Other 
daytime symptoms such as fatigue, memory impairment, personality changes, 
morning nausea, morning headaches, automatic behavior, and depression have also 
been described in some of the patients with OSA. These features are also useful for 
assessing the impact, severity of sleep apnea and the effectiveness of the therapy on 
the patient (Whyte et al., 1989; Hoffstein et al., 1993; Deegan et al., 1996). Table 
1.1 summarizes the symptoms occurs in OSA patients. These symptoms also help 
in clinical diagnosis of OSA. The diagnostic criteria for OSA are summarized in 
Table 1.2. After diagnosis of OSA, the severity of the patient is usually classified 
by the frequency of abnormal respiratory events during sleep. The grading of 
severity is summarized in Table 1.3. 
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Noctural Daytime 
snoring excessive daytime sleepiness 
witnessed apneas fatigue 
coking or gasping memory impairment 
frequent arousals personality changes 
sleep maintenance insomia morning nausea 
nocturia and enuresis morning headaches 
diaphoresis antomatic behavior 
impotence depression 
Table 1.1 Summary of symptoms (both noctural and daytime) occuring in OSA 
patients. 
a. Excessive daytime sleepiness that is not better explained by other factors 
b. Two or more of the following that are not better explained by other factors: 
Choking or gasping during sleep 




c. Overnight monitoring demonstrates five or more obstructed breathing events per 
hour during sleep. These events may include any combination of obstructive apneas/ 
hypopneas or respiratory effort-related arousals. 
Table 1.2 Diagnostic criteria for OSA. The patient suspected of OSA must fulfill 
criterion a or b, plus criterion c. (Adapted from American Academy of Sleep 
Medicine Task Force) 
Grading frequency of abnormal respiratory events during sleep 
Mild 5—15 events/hour of sleep 
Moderate 15-3 0 events/hour of sleep 
Severe More than 30 events/hour of sleep 
Table 1.3 Grading of severity of OSA based on the frequency of abnormal 
respiratory events during sleep. (Adapted from American Academy of Sleep 
Medicine Task Force) 
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1.1.2 Causes of OSA 
There are many causes and risk factors of OSA in human. These include the 
predisposition of the upper airway narrowing such as retrognathia, micrognathia, 
tonsillar hypertrophy, macroglossia, and inferior displacement of the hyoid. 
Nevertheless, the most common physical finding in patients with OSA is a 
nonspecific narrowing of the oropharyngeal airway, with or without an increase in 
soft tissue deposition (Deegan et al.，1995). There are other risk factors commonly 
cause OSA which include obesity and hypertension. Obesity particularly in the 
upper body is commonly found in many patients with OSA. Previous studies 
demonstrated the evidence that patients with OSA are particularly prone to having 
fat necks. Neck circumference with value less than 37cm and greater than 48cm are 
correlated with a low and high risk of OSA respectively (Stradling et al., 1991; 
Hoffstein et al., 1993). Strong correlations between sleep apnea and hypertension 
have been consistently illustrated previously in many studies (Nieto et al., 2000; 
Peppard et al., 2000; McNicholas et al., 2007). The likelihood of OSA appears to 
be particularly high in patients with drug-resistant hypertension (Logan et al., 
2001). 
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1.1.3 Complications of OSA 
In adults, untreated OSA upshot in excessive daytime sleepiness (EDS) 
(Guilleminault et al.，1988)，cognition dysfunction (Engleman et al.，1999; Beede et 
al.，2002), cardiovascular diseases and brain damage (Kryger et al., 2005). EDS 
results in significant impairments in quality of life, cognitive performance, and 
social functioning (Finn et al., 1998; Akashiba et al., 2002; Engleman et al., 2004). 
Likewise, three- to sevenfold raise in the rate of road traffic accidents have been 
described in OSA patients (Teran-Santos et al., 1999; George.，2004) but this can 
be significantly reduced by effective therapy (George., 2001). 
Moreover, different mechanisms may clarify the relationship between OSA and 
cardiovascular disease such as oxidative stress, increased sympathetic activity, 
inflammation, metabolic disturbance and endothelial dysfunction (Douglas et al., 
1996; Shamsuzzaman et al., 2003). OSA is an independent risk factor for the 
development of cardiovascular disease, particularly hypertension, but also coronary 
artery disease, congestive cardiac failure, and stroke (Nieto et al., 2000; Peppard et 
al., 2000; Mooe et al., 2001 ； McArdle et al , 2003; Yaggi et al.，2005; Peker et al , 
2006; McNicholas et al., 2007). Sudden cardiac death and stroke usually occur 
preferentially at night in patients with OSA, but occur in the morning hours for 
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patients without the condition (Garni et al., 2005; Bassetti et al.，2006). On the 
other hand, OSA also associated independently to diabetes and the metabolic 
syndrome (Coughlin et al., 2004; Punjabi et al., 2004; Reichmuth et al., 2005). 
Other cardiovascular risk factors such as obesity, hyperlipidemia, and diabetes also 
revealed to have a high prevalence in OSA patient. This makes the identification of 
the independent association of OSA with cardiovascular disease more difficult 
(Kiely et al., 2000). 
Neuropsychological studies of OSA patients illustrated the impairments in 
cognitive domains related to the prefrontal cortex, such as executive functions 
(Bedard et al., 1991; Naegele et al., 1995) and working memory (Bedard et al., 
1991; Redline et al., 1997; Thomas et al., 2005). Other cognitive functions such as 
alertness (Jokinen et al., 1995; Schlz et al., 1997; Mazza et al., 2005), attention 
(Schulz et al., 1997; Verstraten et al., 2004)，and long-term episodic memory 
(Naegele et al., 1995; Ferini-Strambi et al., 2003) are also revealed to be affected in 
OSA. Some recent studies suggested that impairments in attention play a pivotal 
role in all aspects of cognitive deficits and thereby contribute to the weak 
performance of OSA patients when compared to that of healthy individuals 
(Verstraten et al., 2004; Mazza et al., 2005). 
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Other major neurocognitive manifestation of OSA include personality and 
psychosocial maladjustment patterns, and mental impairment in terms of thinking, 
perception, memory, communication, or the ability to learn new information (Kales 
et al.，1985; Gozal, 1998). Due to obvious ethical reasons, the relative contributions 
of sleep fragmentation and deprivation and those of episodic hypoxemia to the 
neurocognitive deficits exhibited by OSA patients are unclear and cannot be 
elucidated in humans (Berry et al., 1986; Bedard et al., 1991; Morisson et al., 1998). 
Yet, the reductions in general intellectual measures and executive and psychomotor 
tasks are primarily attributable to the severity of hypoxemia, while other attention 
and memory deficits seem to be related to the impaired vigilance induced by sleep 
deprivation and fragmentation from the available correlational studies of 
physiological disturbances during sleep and cognitive deficits in humans (Bedard et 
al., 1991). Nevertheless, this impaired vigilance may not be the only factor 
correlated with excessive daytime sleepiness since the ability to maintain 
wakefulness was substantially disturbed in 322 OSA patients and was inversely 
correlated to the degree of both sleep fragmentation and nighttime hypoxemia 
(Poceta et al., 1992). 
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Effective treatment of the disorder has been linked with major improvements in 
quality of life (Jenkinson et al., 1997; Kiely et al., 1999; McFadyen et al.，2001) 
and also a decreased risk of cardiovascular morbidity and mortality (Peker et al., 
2002; Becker et al., 2003; Doherty et al., 2005; Marin et al., 2005). 
1.1.4 Episodic hypoxia profile 
There are several strategies present that can be used to simulate the physiology of 
OSA in animals. They include identification of animals with spontaneous OSA, 
mechanical occlusion of the airway, delivery of hypoxic gases, and causing 
fragmentation of sleep. The spontaneous OSA is rarely found in animals (0’ 
Donnell et al., 1996; Brooks et al., 1997; Schneider et al., 2000). However, study of 
OSA need to have significant sample size with well-characterized genotypic and 
phenotypic characteristics, so, this method is not feasible. For the mechanical 
occlusion of the airway, the obstruction of the airway need to be sleep-induced and 
terminated by animal arousal. Although this method can best simulate the natural 
physiology of OSA among the above method mentioned, the need to continuously 
assess sleep-wake state makes this method difficult to apply for large sample size. 
Furthermore, sleep fragmentation is only one of the characteristic in human OSA. 
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OSA may or may not be coexist with partial sleep deprivation. Hence, this model 
cannot simulate OSA in a suitable manner and is also not practical (Arzt et al., 
2006). 
The intermittent hypoxia (IH) method is the populated used method now to study 
the effects and reasonale of OSA (Fletcher.，1995; Chaufour et al., 1999; Sica et al., 
2000; Gozal et al., 2000). Exposing animals to IH simulates a pivotal aspect of 
OSA in a noninvasive manner allowing control over the degree of oxyhemoglobin 
desaturation independent of sleep-wake state. It often involves a gas control system 
which regulates the flow of room air, nitrogen, and oxygen into customized cages. 
Animals are exposed to hypoxia for a fixed duration throughout the light phase and 
maintain in normoxia during the dark phase (Polotshy et al., 2003). This IH model 
has been widely studied previously. Fletcher found that chronic IH is related to 
hypertension (Fletcher et al., 1992). It also causes overall reduction in non-REM 
(NREM) and REM sleep in light phase and increases the arousal responses (Gozal 
et al., 2001; Veasey et al., 2004). 
The selected episodic hypoxia profile (EHYP) is aimed to simulate the overall 
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cumulative hourly oxygen desaturation patterns routinely observed in moderately 
severe OSA patients. Previous studies with similar EHYP profile have evident that 
it can induce increases in sympathetic outflow and the systemic and pulmonary 
artery pressures that typically occur in OSA patients (Bakehe et al., 1996; Lesske et 
al., 1997; McGuire et al., 1999). Furthermore, EHYP may have influential effect on 
water maze performance by altering various nonmnemonic factors rather than the 
neural substrates that directly mediate learning and memory. These could include 
bodyweight, sensorimotor function, thermoregulation, and fear and stress responses 
(Shukitt- Hale et al., 1994; Mabry et al., 1996; Youngblood et al., 1997). These also 
meet with some symptoms that occur in OSAS patient as mentioned previously. 
But there are also limitations of the EHYP profile. Since IH treatment was 
continuously given to the mouse, sleep recovery may occur during the treatment 




Hippocampus is an important structure in the brain shown to have main functions 
in memory and regulation of corticosteroid production. In this discussion, we 
mainly focus on the ftmction of hippocampus on memory. 
1.2.1 General Structure of Hippocampus 
The hippocampus is one of the structures of the forebrain, located in the medial 
temporal lobe. Figure 1.1 A shown the anatomy of the human brain and the location 
of the hippocampus. Hippocampus belongs to the limbic system and has a large 
"C"-shaped structure that forms part of the medial wall of the cerebral hemisphere. 
For humans and other mammals, they have two hippocampi, one in each side of the 
brain (Duvemoy., 2005). 
The hippocampus can be mainly divided into few structures. Dentate gyrus (DG) is 
actually a segregate structure with a tightly packed layer of small granule cells 
wrapped around the end of the hippocampus proper which forms a pointed wedge 
in some cross-sections and a semicircle in others. A series of Cornu Ammonis areas: 
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CA4 (which underlies the dentate gyrus), CAS, CA2 (a very small zone), and CAl. 
The CA areas are all with densely packed pyramidal cells inside similar to those of 
the cortex. The CA2 field is a narrow zone of cells located between CAS and CAl 
that have large cell bodies like CA3 but did not receive mossy fiber innervation like 
CAl. The term "hippocampus proper" refers to the four CA regions while 
"hippocampal formation" refers to the hippocampus proper plus dentate gyrus and 
subiculum. After CAl, the subiculum comes which follows by the presubiculum 
and parasubiculum, then a transition to the cortex proper (mostly the entorhinal 
area of the cortex) (Amaral et al., 2006). Figure 1.1 B shown the simplified cross 
sectional structure of the hippocampus. 
Besides, hippocampus is a laminar structure with similar organization in all fields 
of it. The major cellular layer is the pyramidal cell layer, while on the contrary the 
stratum oriens is the narrow and relatively cell-free layer located deep to it. Further 
deep to the stratum oriens is the fiber-containing alvenus. In the CAS field, but not 
in CAl or CA2, stratum lucidum is situated just above the pyramidal cell layer 
which is occupied by the mossy fiber axons originating from the dentate gyrus. The 
border of CA2 and CAS is divided by the stratum radiatum, which is a slight 
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thickening with mossy fibers bending temporally in the distal end of the stratum 
lucidum. The stratum radiatum is the suprapyramidal region in which CAS to CAS 
assocications and CAS to CAl Schaffer collateral connections are located. The 
most superficial portion of the hippocampus is the stratum locunosum-moleculare 
which perforates pathway fibres from the entorhinal cortex travel and terminate 
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Figure 1.1 The basic anatomy of brain and the location of hippocampus were 
shown in (A). The image on the left is the surface of the brain, viewed from the 
side, showing the major lobes (frontal, parietal, temporal and occipital) and the 
brain stem structures (pons, medulla oblongata, and cerebellum). The image on the 
right is a side-view showing the location of the limbic system inside the brain. The 
limbic system consists of a number of structures, including the fornix, 
hippocampus, cingulate gyrus, amygdala, the parahippocampal gyrus and parts of 
the thalamus (Adapted from American Health Assistance Foundation). The 
simplified structure of hippocampus was shown in (B). Dentate gyrus (DG); Comu 
Ammonis areas: CAl, CA2, CA3 and CA4; Subiculum (Sub); Entorhinal cortex 
(EC). The laminar structure of the hippocampus is shown in (C). The hippocampal 
subregion CA3-CA4 (the area of morphometry) is indicated in black, stippled, and 
hatched areas. Black areas: suprapyramidal (SP), intra- and infrapyramidal (IIP) 
and hilar (CA4) mossy fiber terminal fields originating from the dentate gyrus. 
Stippled area: strata oriens (OR) and radiatum (RD). Hatched area: stratum 
lacunosum-moleculare (LM). CAl, subregion of the hippocampus without mossy 
fibers; FI, fimbria hippocampi; FD, fascia dentata; OL and ML, outer and middle 
molecular layers of the fascia dentata; SG, supragranular layer; GC, granular cells. 
(Adapted from Sluyter et al., 2005). 
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1.2.2 The neuronal circuitry of hippocampus 
The neuronal circuitry of hippocampal signal just flow like a loop. Major external 
input comes from the entorhinal cortex (EC) through the axons perforant path. 
These axons origin from layer 2 of the EC and terminate in the dentate gyrus (DG) 
and CAS. There is also a distinct pathway from layer 3 of the EC directly to CAl. 
The perforant path-to-dentate gyrus-to-CA3 -to-CA1 was called the trisynaptic 
circuit. Granule cells of DG send their axons (mossy fibers) to CA3. CA3 
pyramidal cells send their axons to CAl. CAl pyramidal cells send their axons to 
the subiculum and deep layers of the EC. Neurons in subiculum send their axons 
mainly to the EC (Naber et al., 2000; Pieterke et al., 2000). Perforant path input 
from EC layer II goes to the dentate gyrus and is carried to CAS and mossy cells, 
located in the hilus of the dentate gyrus, which further send the information to 
distant portions of the dentate gyrus where the cycle is repeated. CAS combines the 
input signals with those from EC layer II and sends vast connections within the 
region and to CAl via Schaffer collaterals. CAl region receives input from the 
CA3 subfield, EC layer III and the nucleus reimiens of the thalamus. CAl then 
further projects to the subiculum and sending information along the output paths of 
the hippocampus. The subiculum combine information from the CAl projection 
and EC layer III and send these information along the output pathways of the 
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hippocampus (Shepherd., 1998; Duvemoy., 2005). The simplified neuronal 
circuitry was shown in Figure 1.2. 
There are various of sources that can activate and modulate the intrinsic 
hippocampal circuitry when afferents to the hippocampus. They comprises of 
various cortical areas, the amygdaloid complex, the medial septal - diagonal band 
complex, the thalamus, the supramamillary region and the mesencephalic raphe 
nuclei and locus coeruleus. On the other hand, the efferents from hippocampus are 
the efferents of the comu ammonis, contributions of the subiculum to the 
precommissural fornix and the "non-fomical" efferents (Duvemoy., 2005). 
Hippocampus is a relatively complex structure with different networks which have 
been mainly demonstrated to be function in memory such as storage and retrival of 
memory consequences in context. The dentate and CAS probably store 
autoassociations and heteroassociations respectively in their synapses of the 
recurrent connections. When memory retrieval is needed, the networks work 
together to produce an accurate time-compressed recall of a stored sequence 
18 
(Lismam., 1999). Yet，the roles of different hippocampal pathway still remain much 
unknown due to its complexity. 
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Figure 1.2 The simplified neuronal circuitry of hippocampus. The hippocampall 
circuitry is mainly a uni-directional network, with input from the Entorhinal Cortex 
(EC) that forms connections with the Dentate Gyrus (DG) and CAS pyramidal 
neurons via the Perforant Path (PP). The PP is further divide into lateral (LPP) and 
medial (MPP), CAS neurons also receive input from the DG through the mossy 
fibres (MF). They send axons to CAl pyramidal cells via the Schaffer Collateral 
Pathway (SC) and to CAl cells in the contralateral hippocampus via Associational 
Commissural pathway (AC). CAl neurons also receive input directly from the 
Perforant Path and send axons to the Subiculum (Sb). These neurons in turn send 
the main hippocampal output back to EC forming a loop. (Adapted from Wang et 
al.，2005) 
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1.2.3 Cell types of Hippocampus 
There are many cell types coexisting in hippocampus. They include pyramidal cell, 
basket cells, intemeuron and granule cell. Pyramidal cell makes up the vast 
majority of neurons in the pyramidal cell layers. It is also called pyramidal neuron 
or projection neuron. It has a triangularly shaped soma (cell body), a single apical 
dendrites extending towards the pial surface into the stratum oriens, multiple basal 
dendrites extending to the hippocampal tissue, and a single axon. These pyramidal 
neurons are densely packed in hippocampus. They release glutamate as their 
neurotransmitter, and hence functions as the major excitatory component in the 
hippocampus. The schematic drawing of typical hippocampal pyramidal neuron 
was shown in Figure 1.3. Basket cells are various in sizes and shapes. They are 
inhibitory GABAergic intemeurons. Apart from hippocampus, they can also be 
found in molecular layer of cerebellum and the cortex. Their cell bodies are 
situated in the pyramidal cell layer. It also has apical and basal dendritic trees. But 
in comparison to pyramidal cells, their dendrites have fewer dendritic spines and 
have an overall beaded appearance. Intemeurons are sometime also called 
association neuron or bipolar neuron. Their cell bodies are always located in the 
central nervous system (CNS) like the motor neurons. In hippocampus, there are 
different types of intemeurons. Basket cells, bistratified cells and radial trilaminar 
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cells are also intemeurons that can be found in superficial layers of stratum 
radiatum in hippocampus. Granule cells refer to those tiny neurons that are around 
10 micrometres in diameter. They can be found in the granular layer of the 
cerebellum, layer 4 of cerebral cortex, the dentate gyrus of the hippocampus, and in 
the olfactory bulb. Although granule cells in different brain regions are 
anatomically similar, they are functionally diverse. Granule cells in the dentate 
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Figure 1.3 The schematic drawing of typical hippocampal pyramidal neuron. 
(Adapted from Jaff., 2005) 
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1.2.4 Functions of Hippocampus 
There are several functions of hippocampus. They include the control of 
corticosteroid production (Swaab et al,, 2005)，memory and space (spatial memory). 
The critical role of hippocampus in memory began with the report by Scoville and 
Milner from the results of surgical destruction of hippocampus in a patient known 
as H.M. The accidental outcome of the surgery was severe amnesia, the disability 
of the patient in consciously remembering events that occurred after his surgery or 
for several years before it (Scoville et al., 1957). It is now widely accepted that the 
hippocampus plays pivotal roles in memory. In mammals, many types of memories 
depend on hippocampal processing during the first days to few weeks. However, 
this hippocampus-directed process of stabilization eventually ends and memories 
become hippocampus-independent (McClelland etal.，1995; Squire et al.，1995). 
Both neuroscientists and psychologists agree that hippocampus has an important 
role in formation of new memories about experienced events (episodic or 
autobiographical memory) (Eichnbaum et al., 1993; Squire et al., 2002). 
Furthermore, hippocampus as part of medial temporal lobe is also important in 
declarative memory (memories that can be explicitly verbalized such as memory 
for facts) (Squire et al., 1992). Besides formation of new memory, hippocampus 
also has critical function in memory consolidation (Izquierdo et al., 1997; 
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McGaugh., 2000; Izquierdo et al., 2006). 
Selective populations of hippocampal neurons degenerate in Alzheimer's disease 
and in specific types of amnesia. In Alzheimer's disease, the first symptoms appear 
are the memory problems and disorientation. These probably can be explained by 
the first regions of the brain being suffer is the hippocampus (Morrison et al., 2002). 
The important role of hippocampus in learning and memory has also been 
intensified by the discovery of LTP, by demonstrations of LTP of synaptic efficacy 
in most components of intrahippocampal circuitry (Yun et al., 2007). 
Notwithstanding, studies from animal model have shown that an intact 
hippocampus is essential for simple spatial memory tasks. There are different 
phases of spatial memory includes encoding, consolidation and retrieval. Different 
parts of hippocampus shows different functions towards memory. The dentate 
gyrus works in pattern separation. This can be shown by the fact that lesions of the 
dentate gyrus impair performance in a spatial matching-to-sample task (Gilbert et 
al., 2001). CAS works in pattern completion which means the reconstruction of a 
complete output pattern from a degraded input (Rolls et al., 2006). CAl has role 
as a novelty detector detecting mismatches between cortical information 
concerning the current situation, with the stored predictions arriving from CAS 
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(Eichenbaum et al., 1990; Lisman et al., 2001), which is one of the ways of 
memory consolidation. The resulting novelty signal might then trigger the updating 
of stored information to eliminate the mismatch (Lisman et al., 2005). 
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1.3 Memory Formation and Long term potentiation 
In vertebrates, memory can be divided mainly into two phases: a protein and RNA 
synthesis-independent phase that lasts minutes to 1-3 h (short-term memory, STM) 
and a protein and RNA synthesis-dependent phase that lasts several hours to days, 
weeks or even longer long-term memory (LTM) (Dash et al., 2004; Emptage et al., 
1993; Izquierdo et al., 1998; McGaugh et al., 2000). During memory formation, 
protein synthesis seems to be critical for transforming newly learned information 
into stable synaptic modifications (Davis et al., 1984; Dudai et al., 1996; McGaugh 
et al., 2000). Behavioral studies by using different animal species have shown that 
de novo protein synthesis around the time of training or during the first few hours 
post-training is necessary for LTM (Ghirardi et al., 1995; Igaz et al., 2002; Scharf 
et al., 2002). During transition from STM to LTM, a process defined as memory 
consolidation is needed. There are two types of memory consolidation: a fast and a 
slow process. Fast process involves early molecular and cellular events occurring 
early after training and lasting no more than several hours to a few days in specifoc 
brain regions involved in acquisition and early processing of new information 
(synaptic or cellular consolidation) (Dudai., 2000). The slow process needs the 
participation of neocortical regions and their interactions with the medial temporal 
lobe structures (MTL) that reorganize the recently learned material (systems 
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consolidation) (Dudai et al., 2004). This memory consolidation involves different 
molecular events with activation of different signaling cascades in specific brain 
regions especially in hippocampus (Izquierdo et al., 2006). Previous studies found 
that these signaling cascade activated by receptor activation involves AMP A, 
metabotropic and particularly NMDA glutamate receptors, BDNF and monoamines 
receptors (Izquierdo et al., 1997; McGaugh et al., 2000; Kandel et al., 2001; Dudai 
et al., 2004; Izquierdo et al., 2006; ). They are then followed by recruitment of 
secondary messenger and activation of different protein kinases and phosphatases. 
Four signaling pathways control this process: cAMP-dependent protein kinase 
(protein kinase A), calcium-calmodulin kinases, protein kinase C, and 
mitogen-activated protein kinase (MAPK). All of the above four pathways 
mentioned converge to signal to the cAMP-response element-binding protein 
(CREB), a transcription factor which binds to the promoter regions of many genes 
associated with memory and synaptic plasticity (Impey et al., 1998; Impey et al., 
2004; Barco et al., 2006), and activate transcription and translation which produce 
protein required for functional and structural changes needed for memory 
consolidation. The consolidation of LTM needs the growth of new connections and 
the rearrangements of existing ones (Bailey et al., 2004; Bekinschtein et al., 2007). 
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Memory formation in the mammalian brain is mostly widely studied by means of 
long-term potentiation (LTP) of chemical synaptic transmission and the converse 
process of long-term depression (LTD). LTP is defined as the long-lasting 
enhancement in cormnunication between two neurons that results from stimulating 
them simultaneously while LTD is resulted in long lasting decrease in synaptic 
efficacy. LTP is resulted from coincident activity of pre- and post-synaptic 
elements, which resulted in facilitation of chemical transmission that lasts for hours 
in vitro or persist for periods of weeks or months in vivo (Abraham et al., 2002). 
LTP was first found in hippocampus and has been extensively studied by means of 
electrophysiological, biochemical and molecular techniques (Bliss et al., 2007). 
LTP is typically induced by high-frequency stimulation (HFS) of excitatory input 
resulting in rapid elevation of calcium in postsynaptic dendritic spines. Figure 1.4 
shows the illustration of extracellular recording of LTP in vitro induced by tetanic 
stimulation of the Schaffer-commissural projection to CAl pyramidal cells in a 
transverse hippocampal slice. In most of the excitatory synapses, this critical 
calcium influx mainly come from the activation of N-methyl-D-aspartate (NMDA) 
type glutamate receptors, voltage gated calcium channels and mobilization of 
calcium from intracellular stores. It is widely accepted that maintenance of LTP 
involves at least two phases; the early and late phase LTP. Early LTP can last for 
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about 1-2 hours requires covalent modification of existing proteins and protein 
trafficking at synapses, but not new protein synthesis (Lisman et al., 2002; 
Malinow et al, 2002; Malenka et al.，2004). On the other hand, late LTP 
development (like long-term memory), depends on de novo mRNA and protein 
synthesis (Davis et al., 2000; Raymond et al., 2000; Kandel, 2001; Kelleher et al., 
2004). 
LTP is experience-dependent, induced rapidly and cooperatively and can be 
induced in an associative manner. These properties make it an attractive 
mechanism for the storage of information (Cooke et al., 2006). The critical role of 
LTP in memory has been shown in many previous studies by blocking the 
induction or expression of LTP in the hippocampus on the impairments of learning 
and memory (Morris et al., 1986; Pastalkova et al., 2006; Malenka et al., 2004; 
Rumpel et al., 2005; Shimizu et al., 2000). Many studies have demonstrated the 
similarity in molecular mechanisms between memory and LTP. NMDA receptor 
blockage impairs learning in rodents in a variety of hippocampus-dependent 
memory tasks and prevents induction of hippocampal LTP (Villarreal et al., 2002; 
Lamsa ea at., 2007). Both CAMKII-dependent signaling and cAMP-dependent 
signaling have been proved to have substantial roles in both LTP and learning and 
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memory. Mice with mutation in alpha CaMKII have an intense deficit in 
hippocampus-dependent learning and memory and also completely fail to initiate 
LTP induction in the hippocampal CAl subfield by standard stimulation protocols 
(Cooke et al., 2004). Overexpression of a regulatory subunit in the 
cAMP-dependent cascade can greatly reduced the PKA activity and prevents both 
long-lasting LTP and long-term memory. In addition, overexpression of adenylyl 
cyclase in a transgenic mouse increases the cAMP level and so enhances both LTP 
and learning (Wang et al.，2004). In transgenic mice with repressor of CREB or 
target disruption in CREB has been proved to have deficits in sustainable LTP and 
hippocampus-dependent long-term memory (Bozon et al., 2003). This series of 
results also suggests the important role for the cAMP-dependent signaling cascade 
in both long-lasting LTP and memory in mammals. 
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Figure 1.4 Illustration of extracellular recording of LTP in vitro induced by titanic 
stimulation of the Schaffer-commissural projection to CAl pyramidal cells in a 
transverse hippocampal slice. The laminated organization of the hippocampus 
lends itself perfectly to extracellular recording techniques, allowing selective 
pathways to be stimulated and the evoked synaptic responses generated by a 
population of target neurons to be monitored for prolonged periods of time. Two 
metal stimulating electrodes are placed on either side of the recording electrode to 
evoke responses in overlapping populations of pyramidal cells through different 
sets of synapses, which is shown in A. Typical synaptic responses recorded from 
the apical dendritic region of the CAl subfield following stimulation of the 
Schaffer-commissural pathway was shown in B. A tetanus (a brief, high-frequency 
train of electrical stimuli) can be used to induce LTP lasting for many hours in the 
tetanized pathway (closed circles); the second, control pathway (open circles) 
receives only test stimulation and is not potentiated following the tetanus to the 
experimental pathway (shown in C). This demonstrates the input specificity of LTP. 
(Adapted from Neves et al., 2008) 
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1.4 Neurotrophins 
Neurotrophins are a family of secretory proteins which comprised of nerve growth 
factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), 
and NT-4/5. The neurotrophins are primarily synthesized as 30-35kDa precursor 
proteins or pro-neurotrophins. This pro-neurotrophins are cleaved by 
pro-convertases at a highly conserved dibasic amino acid cleavage site which then 
generates the mature proteins. The function of neurotrophins can be controlled by 
proteolytic cleavage, and pro- and mature forms of neurotrophins may bind to 
different receptors, eliciting entirely different biological effects. These mature 
proteins have a number of common features, including a similar number of amino 
acids (118-120), close molecular weights (�12kDa), isoelectric points in the 9-10 
range, and 50% identity in the primary structure. They form stable, non-covalent 
dimers and possess six cysteine residues, conserved in the same relative positions, 
which give rise to three intra-chain sulfide bonds (Maisonpierre et al, 1990; 
Maisonpierre et al, 1991). Figure 1.5.A shows the simplified peptide structure of 
neurotrophins. 
All neurotrophins bind to p75 neurotrophin receptor (NTR) in low affinity but 
selectively interact with their individual high-affinity protein kinase receptors of 
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the trk (tropomyosinrelated kinase) family (Kaplan et al, 2000; Chao, 2003; Teng 
et al, 2004). The p75 NTR is a member of the tumor necrosis factor receptor (TNF) 
superfamily (Bothwell, 1995; Kaplan and Miller 2000). This receptor with absence 
of the intrinsic catalytic activity, and signals through a series of protein - protein 
interactions are mediated by its intracellular juxtamembrane and death domains 
(Hempstead, 2002; Lee et al., 2001). It can cause apoptosis in a variety of systems 
(Barrett, 2000). In addition, when the p75 NTR coexpressed with Trk receptors, 
p75 NTR can increase neurotrophin-binding affinity and contribute to ligand 
discrimination for different Trk family members (Bibel et al., 1999; Hempstead, 
2002). In addition, the p75 NTR can also have important roles in cell survival, 
neurite outgrowth, synaptic transmission, plasticity, and cell migration (Dechant et 
al., 2002). NGF binds to TrkA; BDNF and NT-4/5 to TrkB; and NT-3 to TrkC. 
Figure 1.5.B shows the schematic illustration of different neurotrophins binding to 
their cognate receptors. Ligand binding leads to dimerization and 
autophosphorylation of tyrosine residues within the intracellular domains of the 
receptor, which creates docking sites for second messengers. The adaptor proteins 
She and FRS-2 bind to a common docking site coupling to activation of the 
Ras-raf-ERK cascade and the phosphatidylinositol-3-OH kinase (PI3K)/Akt 
pathway. Docking of phospholipase C y (PLC y) to a separate site leads to 
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production of diacylglycerol, a transient activator of protein kinase C (PKC), and 
inositol trisphosphate (IPS), which mobilizes intracellular calcium. By regulating 
gene expression of the above pathways, neurotrophins can function in neuronal 
differentiation, survival and outgrowth during development (Kaplan and Miller 
2000; Patapoutian and Reichardt 2001). These signals can also pass on to the 
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Figure 1.5 Simplified peptide structure of neurotrophins is shown in (A). The 
neurotrophin growth factor family consists of four proteins: NGF, BDNF, NT-3 and 
NT-4/5. The neurotrophins have a characteristic protein structure that distinguishes 
them from other growth factor families. The carboxy-terminal biologically active 
part of the proteins is about 50% identical in all 4 neurotrophins. Identities include 
a characteristic pattern of 6 cysteine residues (C) that form three conserved cysteine 
bridges. The amino-terminal half of the proteins is functional in the biosynthesis of 
the proteins and includes a signal peptide mediating membrane transport and a 
pro-peptide that appears important for protein folding. The mature monomer is 
released from the pro-sequence by proteolytic cleavage at a conserved Lysine 
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(K)/Arginine (R) rich sequence (Adapted from Georg et al., 2007). Schematic 
illustration of different neurotrophins binds to their specific receptors was shown in 
(B). Neurotrophin family members bind specifically to cognate Trk receptors. The 
low-affinity neurotrophin receptor p75 promiscuously binds all of the 
neurotrophins. TrkA is primarily a receptor for NGF, TrkB a receptor for BDNF 
and NT-4/5，and TrkC a receptor for NT-3. These distinct receptors allow various 
neurons to respond selectively to the different neurotrophins (Adapted from Purves 
etal., 2001). 
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1.5 Brain-derived neurotrophic factor (BDNF) 
BDNF is a neurotrophic factor that can be found in brain and the periphery. It is 
synthesized, stored and released from glutamatergic neurons (Lessmann et al., 2003) 
pathways. It can act on certain neurons of the central nervous system and the 
peripheral nervous system that helps to support the survival of existing neurons and 
encourage the growth and differentiation of new neurons and synapses. BDNF is 
active in the hippocampus, cortex and basal forebrain. In addition, it was shown 
that it has critical role in learning and memory. In our studies, we mainly focus on 
the role of BDNF in learning and memory. 
1.5.1 Molecular Characteristics of BDNF 
Both mouse and rat BDNF gene has a complex structure with four short 5'-
non-coding exons (exons I - IV) containing separate promoters and one 3'-exon 
(exon V) encoding the mature BDNF protein. Transcription of the gene results in 
BDNF transcripts containing one of the eight 5’ exons spliced to the protein coding 
exon and in a transcript containing only 5'-extended protein coding exon (Aid et al, 
2007). In the rat BDNF genomic structures, four promoters are followed by four 
short 5'- exons, all of them can be individually spliced onto a common 3,-exon 
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encoding the entire prepro-BDNF protein (Metsis et al. 1993; Timmusk et al. 1993). 
The BDNF gene is a complex structure with multiple regulatory elements and four 
promoters which differentially expressed in central or peripheral tissue. Exon IV 
transcript is predominantly expressed in the lung and heart whereas exon I，II，III 
transcripts are mainly in the brain (Timmusk et al. 1993). The role of multiple 
BDNF promoters are controlling BDNF gene expression at transcription, mRNA 
stability, translation, and subcellular distribution levels, and fulfill the different 
functions of BDNF (such as regulation of neuronal survival, differentiation, 
synaptic transmission, and plasticity). Schematic representation of the BDNF gene 
is shown in Figure 1.6 (Givalois et al., 2001). 
After translation and transcription, the synthesized protein - pro-BDNF undergoes 
N-terminal cleavage at the Arg-Gly-Leu-Thr57-2-Ser-Leu site (Mowla et al, 2001) 
within the trans-GoXgi network and immature secretory vesicles to generate mature 
BDNF (14 kDa). A small amount of a 28-kDa residue protein is also secreted. This 
cleavage is done by the serine protease plasmin system which involve plasmin, 
plasminogen and tPA (Gray et al., 2008). 
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The mature monomers of BDNF are unable to bind to the TrkB receptor. It must be 
first dimerize to form a dimmer of two identical peptides, each of � 1 0 0 amino acids. 
BDNF activates the trkB receptor tyrosine kinase of the tropomyosin-related kinase 
(trk) family. Along with the ionotropic and metabotropic glutamate receptors, trkB 
could couple different signal cascades and function such as synaptic activation to 
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Fig. 1.6 Schematic representation of the BDNF gene. Exons are represented as 
boxes and introns as lines. The eight possible transcripts from the gene are shown 
below the gene scheme, with lines indicating the alternative splicing sites. The start 
codon and polyadenylation signals are indicated by arrows (Adapted from Givalois 
et al.) 
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1.5.2 Expression of BDNF in brain 
BDNF is expressed in a range of tissue and cell types, not just in the brain. It can 
also be found in the retina, the CNS, motor neurons, the kidneys, and the prostate. 
But its synthesis is highest in the CNS. BDNF is active in the hippocampus, cortex 
and basal forebrain. Furthermore, BDNF is the most abundant neurotrophic factor 
in brain with the highest levels of mRNA and protein found in hippocampus and 
frontal cortex (Altar et al., 1997; Conner et al., 1997). 
The expression of BDNF can be affected by many factors. In Central Nervous 
System, the regulation of BDNF can be activity-dependent or regulated by 
peripheral hormones. For the activity-dependent regulation, previous studies shown 
that both glutamate (Zafra et al., 1990; Zafra et al., 1991; Marmigere et al., 2001)， 
GABA (Zafra et al., 1991; Heese at al., 2000; Marmigere et al, 2003), serotonin 
(Vaidya et al., 1997; Duman et al., 1998)，acetylcholine (Berzaghi et al.，1993; 
Kenny at al., 2000) and dopamine (Kuppers et al., 2001; Tapia-Arancibia et al., 
2004) would affect the BDNF expression. And peripheral hormones such as 
estrogen, progesterone, testosterone, glucocorticoids and thyroid hormones would 
also affect BDNF expression (Singh at al., 1995; Schaaf et al., 1998; Viant et al., 
2000; Solum el at, 2002). In addition, BDNF expression also found to be varied by 
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some pathological conditions such as epilepsy, depression, Alzheimer's disease and 
Parkinson's disease. Furthermore, physical conditions such as physical exercise 
and stress also affect BDNF expression (Tapia-Arancibia et al., 2004). 
Molecularly, Ca^ ^ regulates BDNF transcription by a CREB-dependent mechanism 
(Adam et al., 1999). CREB cooperates with other promoter-bound factors to 
stimulate transcription of the BDNF gene in membrane depolarized cells 
(Finkbeiner at al., 1997). CREB activation is importance in the induction of 
long-lasting changes in plasticity and memory (Bourtchuladze et al., 1994). 
Furthermore, robust CREB phosphorylation and DRE-repoiter gene expression are 
detected in cortical neurons during developmental plasticity (Pham et al., 1999) and 
in hippocampal neurons in response to both LTP-inducing stimuli and memory 
training tasks (Impey et al., 1996; Impey et al., 1998). In primary cortical neurons, 
the growth factor brain-derived neurotrophic factor (BDNF) stimulates both 
Ca^Vcalmodulin-dependent kinase IV (CaMKIV) and the Ras-MAPK cascade, 
leading to CREB phosphorylation (Steven, 2000). 
Simplified illustration of the site of phosphorylation at BDNF cognate receptor Trk 
B as well as the transduction pathways activated by phosphorylation on different 
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sites were shown in Figure 1.7. Through CREB regulated process; BDNF can 
increase itself production through positive feedback loop. BDNF dimmer binding 
to TrkB receptor leads to autophosphorylation of tyrosine residues within the 
intracellular domains of the receptor, creating docking sites for second messengers. 
The adaptor proteins She, Grb2 and SOS bind to a common docking site coupling 
to activation of the Ras-raf-MAPK cascade. The activation of 
phosphatidylinositol-3-OH kinase (PI3K) activates the Akt/PKB pathway. Docking 
of phospholipase C y (PLC y) to a separate site leads to production of 
diacylglycerol, a transient activator of protein kinase C (PKC), and inositol 
trisphosphate (IPS), which mobilizes intracellular calcium. Regulation of gene 
expression through these pathways underlies the well established the role of 
neurotrophins in neuronal differentiation, survival and outgrowth during 
development (Kaplan and Miller 2000; Patapoutian and Reichardt 2001). These 
signals can also pass on to the nucleus to activate transcription factors that alter 
gene expression, (Lu, 2003). Since BDNF expression is CREB regulated, the 
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Figure 1.7 Simplified illustrations of the site of phosphorylation at BDNF cognate 
receptor TrkB as well as the transduction pathways activated by phosphorylation 
on different sites. 
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1.5.3 Functions of BDNF 
There are many functions of BDNF. In embryonic neurons, BDNF supports the 
survival and differentiation of specific neuron in vivo (Shetty et al., 1998). Growing 
evidence also indicates that BDNF is also involved in several functions in 
adulthood. They include neuronal homeostasis and brain plasticity-related 
processes such as memory, learning (Tyler et al., 2002) and drug addiction 
(Bolanos and Nestler, 2004). In cellular level, binding of mature BDNF protein to 
TrkB and p75 neurotrophin receptor promotes cell survival, neurite outgrowth, 
synaptic transmission, plasticity and cell migration (Dechant and Barde, 2002). In 
contrast, uncleaved pro BDNF has altered binding characteristics and distinct 
biological activity in comparison with mature BDNF protein (Lee et al., 2001; 
Teng et al., 2005). The relationship between BDNF and memory would be fijrther 
discussed in the next session. 
1.5.4 BDNF and neuronal plasticity 
At hippocampal CAl synapses, BDNF was shown to acutely facilitate long-term 
potentiation (LTP) (Korte et al. 1995; Figurov et al. 1996; Patterson et al. 1996). 
46 
This effect is caused primarily to a presynaptic mechanism (Gottschalk et al. 1998; 
Xu et al. 2000) and has been attributed to a potentiation of synaptic responses to 
tetanic stimulation and an enhancement of synaptic vesicle docking, possibly 
through changes in the levels in phosphorylation of synaptic proteins (Gottschalk et 
al. 1999; Pozzo-Miller et al. 1999; Jovanovic et al. 2000). Previous studies 
demonstrated postsynaptic effects of BDNF on dentate LTP in slices and on 
NMDA receptors in cultured hippocampal neurons (Levine et al.,1998; Kovalchuk 
et al., 2002). In the visual cortex, BDNF has been shown to facilitate LTP 
(Akaneya et al., 1997; Ruber et al.,1998; Jiang et al. 2001) and attenuates LTD in 
layer II/III synapses of young adult rats (Akaneya et al. 1996; Huber et al. 1998; 
Kinoshita et al. 1999; Kumura et al. 2000). 
On the other hand, induction of LTP in the hippocampus can rapidly and 
selectively increases BDNF mRNA levels (Patterson et al., 1992; Castren et al, 
1993). BDNF mRNA in the hippocampus can be induced by learning, training, and 
short- or long-term memory formation processes (Hall et al., 2000; Alonso et al., 
2002; Yamada et al., 2003). Formation of a social recognition memory increases 
BDNF and trkB expression in cortical and limbic regions in lambs (Broad et al,, 
2002). BDNF mRNA is also up-regulated in the inferior temporal cortex during 
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declarative memory formation in monkeys (Tokuyama et al., 2000) or in the rat 
hippocampus during contextual fear learning. 
In hippocampal pyramidal neurons, BDNF was found to be stored in dendritic 
processes in secretogranin Il-positive secretory granules, which is released in 
response to HFS (Blochl and Thoenen, 1996; Hartmaim et al., 2001; Kohara et al., 
2001; Balkowiec and Katz, 2002). These properties make BDNF attractive as a 
bidirectional modulator of excitatory synaptic transmission and plasticity. BDNF 
can regulate protein synthesis through both transcriptional and post-translational 
mechanisms. Furthermore, BDNF is capable of stimulating its own release through 
the positive feed back loop. These two properties of BDNF make it important for 
synaptic consolidation possible by allowing sustained and regenerating signaling at 
synaptic sites. 
According to previous studies, the action of BDNF to neuronal plasticity can be 
divided into permissive and instructive mechanism. Release of BDNF maintains 
the presynaptic release machinery, enabling sustained presynaptic transmission 
during HFS and make synapses capable of LTP, but these are not causally involved 
in generating LTP. In contrast, instructive refers to BDNF signaling that is initiated 
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in response to HFS and causally involved in the development of LTP. LTP is 
impaired in mice lacking the BDNF gene (Korte et al., 1995). Deficient in 
endogenous BDNF leads to impairment of spatial learning and memory in adult 
rats (Mu et al., 1999). But treatment with BDNF of hippocampal slices dissected 
from knockout mice can rescue the deficits in LTP and significantly improves 
deficits in basal synaptic transmission at the Schaffer collateral-CAl synapse 
(Patterson et al., 1996). According to Figurov, inhibition of BDNF signal enhanced 
synaptic fatigue and impaired both the induction and early maintenance of LTP at 
CA3-CA1 synapses (Figurov et al., 1996). But when BDNF was applied to the 
hippocampal slices of early postnatal rats with low endogenous BDNF level, their 
synaptic fatigue decrease and LTP induction then facilitated. After that, Gottschalk 
and Pozzo found that the enhancement of synaptic fatigue and impairment of LTP 
obtained was correlated with the reduced expression of the synaptic 
vesicle-associated proteins synaptobrevin and synaptophysin and a reduction in the 
proportion of docked (readily releasable) vesicles in the active zone (Gottschalk et 
al., 1998; Pozzo et al.,1999). On the other hand, the effect on synaptic fatigue and 
LTP can be restored by 3-4 hours incubation of BDNF on slices obtained from 
BDNF knockouts mice which restores expression of presynaptic proteins. This 
incubation involves both transcription-dependent and transcription-independent 
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mechanisms (Tartaglia et al., 2001). Furthermore, the transcription of a small 
GTP-binding protein (RabSa) which is important for trafficking transmitter vesicles 
to the active zone can be enhanced by BDNF incubation on hippocampal cultures 
(Thakker-Varia et al., 2001). The above also evident the permissive features of 
BDNF to synaptic plasticity by facilitate the frequency dependent transmission and 
LTP induction through regulated synthesis of proteins involved in vesicle 
trafficking and neurotransmitter exocytosis. 
Endogenous BDNF are also capable of modulating LTP without affecting synaptic 
fatigue by using instructive mechanism. LTP induction can be directly gated by 
puffs of BDNF through rapid modulation of postsynaptic calcium influx under 
weak HFS (Kossel et al., 2001). In early LTP, BDNF is required for presynaptic 
expression of LTP in CAl region and presynpatic source of BDNF is critical for 
this expression (Zakharenko et al., 2001; Zakharenko et al., 2003). TrkB antibody 
inhibited the development of late LTP while leaving early LTP almost completely 
intact using a spaced HFS protocol (Kang et al., 1997). This suggests that late LTP 
depends on a critical period of TrkB signaling after HFS. Long lasting increases in 
synaptic efficacy can be elicited by bath perfusion of BDNF for several minutes 
which dubbed BDNF-induced LTP in hippocampal slices (Kang et al., 1995; Kang 
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et al.，1996). BDNF can enhance the potassium-evoked glutamate transmitter 
release from synaptosomes during maintenance phase of BDNF-LTP (Errington et 
al., 2003). 
1.6 Tissue Plasminogen Activator - Plasmin System 
The tissue plasminogen activator - plamin system mainly involves tissue 
plasminogen (tPA), plasminogen and plasmin. Its widely distributed in mammal 
body include surface of endothelial cells of veins, capillaries, the pulmonary artery, 
heart, uterus, secreted after vascular injury and the central nervous system such as 
brain. In our study, we mainly focus on the action of this tPA-plasmin system in 
brain. 
1.6.1 Molecular Characteristics of Tissue Plasminogen 
Activator - Plasmin System 
Tissue plasminogen activator - plasmin system mainly consist of tPA, plasminogen 
and plasmin. There are two types of mammalian plasminogen activator (PA): tissue 
type (tPA) and urokinase-type (uPA) plasminogen (Carmeliet et al., 1994). The 
tPA mediated pathway is primarily involved in fibrin homeostasis while uPA 
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mediated pathways is primarily involved in phenomena such as cell migration and 
tissue remodeling (Collen et al, 1999). tPA expression is regulated by the binding 
of the cytoplasmic polyadenylation element binding (CPEB) protein which leads to 
the extension of tPA mRNA polyadenylation and a subsequent increase in tPA 
protein synthesis. PAs are serine protease that cleaves proenzyme plasminogen at 
Arg561-Val562 peptide bond to generate active protease plasmin. The active site of 
serine protease consists of a "catalytic triad" composed of the amino acids serine, 
aspartic acid, and histidine. The active site is located in the carboxyl-terminal 
region of the molecules while the amino-terminal contains one or more structural 
or functional domains. tPA has molecular weight of 68 kDa. It consists of 530 
amino acids which form several domains with homologies to other proteins. They 
includes: a finger domain comprising residues 4-50, a growth factor domain 
comprising residues 50-87, two kringles comprising residues 87-176 and 176-262, 
and the protease domain constituted by residues 276-527 which forms the catalytic 
triad. The human tPA gene is localized in chromosome 8 (bands 8.p.l2-> q.11.2). 
In neurons, tPA is stored in secretory vesicles and can be released after membrane 
depolarization or stimulation (Gualandris et al., 1996; Parmer et al., 1997). 
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Plasminogen is synthesized as a single chain, after cleavage by tPA, it becomes a 
two chain disulfide linked plasmin. Plasminogen has 92 kDa while plasmin has 85 
kDa. Plasminogen consists of 791 amino acids which are organized into seven 
structural domains. The "preactivation peptide" consist amino acid residues 1-77; 
five sequential homologous kringle domains consist disulfide-bonded triple loop 
structures of about 80 residues each; and the protease domain formed from residues 
562-791. The human plasminogen gene is located on the long arm of chromosome 
6 at band q26 or q27. Each of the five kringle domains is encoded by two exons 
separated by a single intron in the middle of each structure (Collen et al., 1999; 
Collen et al., 2001). 
This system is tightly regulated by serine protease inhibitors (serpins) which 
include plasminogen activator inhibitor-1 (PAI-1) and neuroserpin for tPA. For 
plasmin, it can be inhibited by a2-antiplasmin (a2-AP). tPA activity can be reduced 
through rapid clearance by low-density lipoprotein receptor-related protein 
(LRP)-mediated endocytosis (Collen et al., 2001). In the brain, tPA can be found to 
be highly expressed in hippocampus, amygdale, cerebellum and hypothalamus. 
Both the neurons and microglial cells express tPA. Except tPA, other molecules 
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involve in the tPA - plasmin system also can be found in the brain, they include 
plasminogen, PAI-1 and neuroserpin (Teesalu et al., 2000; Salles et al.，2002). 
1.6.2 Functions of Tissue Plasminogen Activator • Plasmin 
System 
The tPA mediated pathway is primarily functioned in fibrin homeostasis while uPA 
mediated pathways is primarily functioned in phenomena such as cell migration 
and tissue remodeling (Collen et al., 1999). Increased enzymatic activity leads to 
hyperfibrinolysis which results in excessive bleeding; while decreased activity 
leads to hypofibrinolysis which results in thrombosis or embolism (Agren et al., 
2007). Homozygous deficiencies of several plasminogen system components 
(include both tPA and uPA) have not been observed in human since these 
inactivation in both genes would probably cause embryonic lethality. On the other 
hand, for single or combined deficiencies of tPA，uPA, PAI-1, plasminogen or 
a2-AP in mice, it results in apparent normal at birth but some develop ulceration 
and rectal prolapse (Melchor et al., 2005). 
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In the Central Nervous System, the tPA-plasmin system is also important in 
learning and memory, stress, neuronal degeneration, addiction and Alzheimer's 
disease (Tsirka et al., 2002; Pang et al., 2004; Ledesma et al., 2005; Pawlak et al., 
2005). Most of the above functions are mainly due to the role of tPA in synaptic 
plasticity. tPA is an immediate-early gene with mRNA transcription induced 
shortly after synaptic activity such as LTP (Qian et al., 1993). tPA expression is 
increased after LTP while late phase LTP (L-LTP) or long term depression (LTD) 
would be affected by inhibition of proteolytic activity or deficiency in tPA. On the 
other hand, increased in tPA would facilitates LTP and learning (Baranes et al.， 
1998; Pawlak etal., 2002). 
In hippocampus, plasmin can cleave precursor pro-BDNF to its mature form 
mBDNF. Impaired L-LTP in hippocampal slices of both tPA-deficient and 
plasminogen-deficient mice can be rescued by application of mBDNF derived from 
tPA/plasmin cleavage (Pang et al., 2004). tPA mRNA was up regulated in the rat 
hippocampus after seizure，kindling and LTP (Qian et al., 1993). Enhanced LTP in 
hippocampal slices and improved in hippocampal-dependent spatial memory 
formation have been found in mice overexpressing tPA in the CNS (Madani et al., 
1999). Overexpression of tPA led to increased synaptic activity in vivo in mice 
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(Pawlak et al., 2002). In addition to BDNF, tPA can also cleave NRl, which result 
in enhancing NMDA-mediated intracellular calcium levels and neuronal 
degeneration (Nicole et al., 2001). When tPA interacts with lipoprotein 
receptor-related protein (LRP), it results in up-regulation of matrix 
metalloproteinase-9 (MMP-9) which degrade the ECM contributing to either 
synaptic plasticity or neuronal degeneration (Wang et al., 2003). Interaction 
between tPA and LRP also contributes in blood-brain barrier (BBB) breakdown 
(Yepes et al., 2003). 
In amygala, tPA is induced in the medial and central part of amygala after acute 
restraint stress (Pawlak et al., 2003). It also functions in proper control of hormonal 
stress response and emotional learning which are independent of plasmin 
production (Matys et al., 2004). In cerebellum, complicated motor learning process 
can up-regulate tPA mRNA in rats (Seeds et al., 1995). Besides roles in 
hippocampus, amygdale and cerebellum, the tPA-plasmin system also involved in 
the recovery of function in the visual cortex after reverse occlusion. tPA-plasmin 
activity contribute in structural remodeling by pruning dendritic spines and 
reorganizing the ECM (Mataga et al., 2002; Matage et al., 2004). tPA expression is 
increased in the nucleus accumbens and limbic system in morphine and ethanol 
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addiction model. In here, addiction can be considered as a form of adaptive 
synaptic plasticity. tPA activaity can also be increased by ethanol consumption and 
withdrawal (Nagai et al., 2004; Pawlak et al., 2005). The tPA-plasmin system also 
have other functions in the CNS such as serpins in CNS pathology, tPA in 
neurotoxicity and Alzheimer's disease, but this would not further discuss in here. 
Some of the main functions of the tPA-plasmin system were summarized at Figure 
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Figure 1.8 The Schematic representation of the tPA-plasmin system. The 
proenzyme plasminogen is converted to the active enzyme plasmin by tPA or uPA. 
Plasmin can degrade fibrin to FDP and convert pro-MMP to active MMPs which 
can then further degrade ECM. Pro-MMP can also be activated by UPA or other 
MMP directly. The tPA activated pathways are mainly involved in fibrin 
homeostatsis while the uPA activated pathways are mainly involved in tissue 
remodeling. These pathways can be regulated by inhibition by a2-antiplasmin at the 
level of plasmin and by TIMP at the level of MMPs. (Adapted from Collen et al., 
1999) 
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1.7 Aim of the study 
It is well known that obstructive sleep apnea and associated intermittent hypoxemia 
cause deficit in learning and memory in human. As discussed in previous sections, 
memory formation involves a cellular process known as long-term potentiation 
(LTP). Our laboratory found previously that LTP is impaired after intermittent 
hypoxia treatment. There were significant reduction in the magnitude of both early 
phase LTP and late phase LTP in both 7 days IH and 14 days IH when compared 
with the control (Fig. 1.9). We wish to understand the cause of such effects. In this 
study, we first examined if IH would compromise the membrane excitability of 
hippocampal CAl neurons, by means of electrophysiological techniques. 
Surprisingly no work has been done on this important question in detail. Second, it is 
well known that LTP is dependent on the expression of brain-derived neurotrophic 
factor (BDNF). Our laboratory has also shown that BDNF is critical in the 
expression of late-phase LTP suggesting its role in long-term memory formation 
(Pang et al., 2004). Hence, we would like to test the hypothesis that deficits in the 
early and late phase LTP are due to the reduced expression of BDNF. To answer this 
question, the expression of BDNF and various related proteins were analyzed. 
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Figure 1.9. The effect of intermittent hypoxia on early phase LTP was shown in (A). 
The effect of intermittent hypoxia on late phase LTP was shown in (B). Values are 
means 士 SE. * Significantly different from control cells (p<0.05). ** Significantly 
different from control cells (p<0.01). 
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CHAPTER 2 MATERIALS AND METHODS 
2.1 Animal model of obstructive sleep apnea 
There are several strategies that can be used to simulate the physiology of OSA in 
animals. They include identification of animals with spontaneous OSA, mechanical 
occlusion of the airway, delivery of hypoxic gases, and causing fragmentation of 
sleep. Out of the above strategies, we adopted the intermittent hypoxia model 
which is the most suitable model (refer to chapter 1.1.4). Animals were exposed to 
IH environment to simulate a significant aspect of OSA in a noninvasive manner. 
This also allows for controlling the degree of oxyhemoglobin desaturation 
independent of sleep-wake state. But one of the limitations of our model is that the 
delivery of hypoxic gases cannot start at the onset of sleep and subsequent removal 
of the stimulus also cannot be done when arousal or wakefulness of the animals 
occur. In addition, sleep architecture was not assessed. 
2.1.1 Intermittent hypoxia 
Animals were housed in chambers (Figure 2.1 A) with oxygen levels controlled by 
an Oxycycler (Model A84XOV; BioSpherix Instruments, Redfield, NY). The light 
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and dark cycle in the room was set at 12h:12h (light 6:00 AM to 6:00 PM). The 
protocol for chronic intermittent hypoxia was based on previously reported rodent 
models of sleep apnea (Gozal et al., 2001： Xu et al., 2004). Briefly, the O2 
concentration in these chambers was continuously measured by an O2 analyzer and 
was controlled by a computerized system through a gas valve outlet. The O2 
concentration in chambers was programmed and adjusted automatically. Any 
deviation from the desired concentration was corrected by adding pure N2 or O2 
through solenoid valves. Ambient CO2 in the chambers was periodically monitored 
and maintained at 0.03% by adjusting the overall chamber basal ventilation. 
Humidity was measured and maintained at 40-50%. Temperature was kept at 
22-24�C. The intermittent hypoxia profile consisted of alternating 21% and 10% 
O2 during the 8 hours light cycle (9:00 am - 5:00 pm) and mice were placed at 
room air for the remaining 16 hrs. 
The selected intermittent hypoxia (IH) profiles aimed to reproduce the overall 
cumulative hourly oxygen desaturation patterns routinely observed in moderately 
severe OSA patients. The paradigm of IH consists of cycles of oxygen levels 
between 10% and 21% every 90 seconds (40 cycles/hour) during the light phase (8 
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hours) (Figure 2.IB). From previous studies using similar paradigm, the cumulative 
arterial blood gases at various time points during the alternating 10% O2 - room air 
90 sec cycle confirmed the anticipated alternation of moderate hypoxemia with 
normoxemia, such that calculated oxyhemoglobin saturations ranged from 62 to 
70%. These were clearly within the range of those recorded in OSA patients. Mice 
are nocturnal animal. They sleep during daytime and being active at night. To 
simulate the situation in OSA, the hypoxia paradigm was applied at daytime 
instead of night, so as to adapt to the physiological living style of mice. 
At the age of 5-6 weeks, mice C57BL/6 were accommodated in the chamber 
undergoing the hypoxia treatment for 3 days, 7 days and 14 days respectively. The 
control mice were allowed to accommodate in the noraioxia environment. Almost 
100% of the exposed mice survived the time of exposure. Mice usually have life 
expectancy of approximately 2 years. 14 days IH treatment in mouse when 
converted to the human life expectancy, which is approxiamately 70 years, is equal 
to nearly 1.5 years. OSA is a chronic disease which can last for years in patient. 
Our simulation meets the severity by means of time of OSA patient range from few 
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Figure 2.1 The computer-controlled chamber used for the induction and 
maintenance of cyclic hypoxia is shown in (A). The paradigm of intermittent 
hypoxia is illustrated in (B). It consists of cycles of oxygen levels between 10% 
and 21% every 90 s (40 cycles/hr) during the light phase (8 hrs). 
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2.2 Electrophysiological recordings 
Electrophysiological recording was used to investigate the effect of intermittent 
hypoxia on the resting membrane properties and excitability of mouse hippocampal 
CAl neurons. 
2.2.1 Preparation of brain slices 
Adult male mice (postnatal 42 days) were used for the preparation of acute brain 
slices. The animals were sacrificed by decapitation and the brains were 
immediately removed and cut into two halves in the sagittal plane. It was then 
immersed in ice-cold artificial cerebrospinal fluid (ACSF) of the following 
composition: 125inM NaCl, 2.0mM KCl，1.2 mM MgSC^，2.5mM CaCl2，1.2 mM 
KH2PO4, l lmM glucose, and 26mM NaHCOs, which was continuously bubbled 
with 95% O2 and 5% CO2. The brains were then glued with the lateral side down 
onto a platform in a chamber filled with oxygenated ice-cold ACSF, and 250 jim 
thick parasagittal sections were cut using a vibrating microtome (Integraslice 
7550MM, Campden Instruments Ltd., Loughborough, UK). Slices were 
preincubated in a holding chamber containing oxygenated ACSF at 34 土 1 °C for at 
least 1 hour before transferring to a recording chamber. After transfer, slices were 
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submerged and perfused at 1.0-1.5 ml/min with oxygenated ACSF maintained at 34 
± 1 
2.2.1 Visualization of hippocampus CAl Neurons 
Hippocampi were directly visualized by means of differential interference contrast 
(DIG) optics of the microscope (Zeiss Axioshop) aided by contrast-enhanced video 
microscopy (Hamamatsu). Hippocampus CAl neurons were used if they fulfill 
the following morphological criteria: smooth surface, a three-dimensional contour, 
and were pyramidal in shape. The CAl neurons were obtained from the control and 
hypoxia-treated mice. Neurons were considered for recording if their resting 
membrane potentials were at least -50mV. 
2.2.3 Patch-Clamp recordings 
Whole-cell patch clamp recordings from the hippocampal CAl neurons were 
obtained using a patch-clamp amplifier (MultiClamp 700A; Axon Instruments, 
Molecular Devices Corporation), digititized at lOkHz, and acquired using a 16-bit 
data acquisition system Digidata 1322A (Axon Instruments, Molecular Devices 
Corporation) under the control of pCLAMP 8.0 (Axon Instruments, Molecular 
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Devices Corporation). Patch pipettes were pulled from borosilicate glass (1.5mm 
O.D., 0.86mm I.D., Sutter Instrument Co.). Pipette resistance was typically 6-8 M 
Q when filled with low chloride internal solutions of following composition: 
ISOmM K- gluconate; lOmM KCl; 2 mM MgCl2.6H20; O.lmM CaCh, lOmM 
HEPES; 2mM ATP-Na2； 0.5mM GTP-Na; and ImM EGTA; pH was adjusted to 
7.25 - 7.3 with IM KOH. Monitoring through a television connected to the camera, 
a pipette was placed on the CAl hippocampus cell and whole-cell recording was 
made. After formation of whole cell configuration, current clamp mode was used. 
The holding current was adjusted until the membrane potential was held at -70 mV 
or -55 mV respectively. Current steps between -160 pA and +160 pA were applied 
in 20 pA increments. The stimulation protocol and a typical result was shown in 
Figure 2.2A and B. 
Passive properties such as membrane resistance and capacitance were assessed by 
applying a slight hyperpolarization of 20 mV. For the active properties, the action 
potential properties including: action potential frequency, threshold step current, 
action potential area, peak amplitude, half-width, maximum decay slope, maximum 
rise slope, time to peak and time to decay half amplitude were recorded. Other 
active properties such as calcium spike and rebound spike were also observed in 
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the neurons recorded. The action potential frequency is the number of action 
potential at each holding current divided by the period of the holding current 
(400ms). The action potential waveforms were analyzed based on the first action 
potential initiated from the threshold positive step current. The definition of action 
potential area, peak amplitude, half-width, time to peak, time to half amplitude rise 
and time to decay half amplitude are shown in Figure 2.2C. The peak amplitude is 
the voltage difference between the resting potential and the peak of the action 
potential. The half-width is the width of the action potential at half-peak amplitude. 
The time to peak is the time needed for the action potential to rise from the resting 
potential to the peak level. The time to half amplitude is the time needed for the 
action potential to rise from resting potential to the half peak amplitude. The time 
to decay half amplitude is the time needed for the action potential to decrease from 
the peak to half peak amplitude. 
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Figure 2.2 The typical stimulation protocol of CAl hipppocampal neurons is 
shown in (A). Depolarizing and hyperpolarization current steps were applied 
between -160 pA and +160 pA in 20 pA increments. The typical resulting traces 
are shown in (B). The various parameters measured are illustrated in (C). 
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2.3 Protein analysis - ELISA 
Enzyme-Linked Immunosorbent Assay (ELISA) was used to investgate the amount 
of different neurotrophins in the hippocampus after normoxia and different 
intermittent hypoxia treatment. In addition, it was also used to investigate the effect 
of intermittent hypoxia, and the recovery, on protein expression of total BDNF in 
mouse hippocampus of different age groups. 
2.3.1 Isolation of mouse hippocampus total protein 
Adult male mice (postnatal 42 days) were used for the preparation of acute brain 
slices. The animals were sacrificed by decapitation. The brains were immediately 
removed and bilateral hippocampi were rapidly dissected and placed on dry ice. 
Sample used for ELISA was lysed by 100 |il of lysis buffer as instructed by the 
manufacturer. The mixture were then sonicated and centrifuged at 13,000 x g for 30 
min at 4°C. Resulting supematants were removed and frozen at -70 °C until 
analysis. Total protein concentration was measured by using a Micro BCA Protein 
Assay Reagent Kit (Pierce Biotechnology, Rockford, USA). In each assay, 
duplicate wells were assigned for each sample. A microplate reader was used to 
measure signal intensity from the wells. 
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2.3.2 ELISA 
ELISA was used to investgate the amount of different total neurotrophin in 
hippocampus after normoxia and different intermittent hypoxia treatment. BDNF 
Emax immunoassay system from Promega, NT-3 Emax immunoassay system from 
Promega, NGF Emax immunoassay system from Promega and Neurotrophin 4/5 
(NT 4/5) Sandwich ELISA Kit from Chemicon International were used for 
investigating the amount of BDNF, NT-3, NGF and NT-4/5 respectively. 
For the first 3 assays (BDNF, NT-3 and NGF)，flat bottom 96 well plates (Thermo 
Electron Immulon 4HBX，USA) were first coated with solution containing a 
monoclonal antibody against the target protein prepared in carbonate coating buffer 
(100 uL/well, 1:1000 dilution) and incubated for 16 hours at 4 °C. Following a 
wash in TBST (Tris buffered saline containing Tween 20), the coated wells were 
incubated with block and sample buffer for 1 hour at room temperature, and 
washed again with TBST. Standard control sample for BDNF was diluted serially 
(1:2) from 300-0 pg/ml and plated to two columns of wells (100 “1/ well) 
designated for standard curve in every plate. The frozen ELISA samples (described 
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above) were thawed on ice, and every sample plated in duplicate for measurement 
of target protein. Following 2 hours incubation at room temperature, wells were 
washed in TBST, and treated with solution containing a polyclonal antibody 
against the target protein (the second primary antibody solution; 1:500) for 2 hours. 
Then, the wells were washed in TBST, treated with appropriate secondary antibody 
conjugated to peroxidase for 1 hour, washed again in TBST, and treated with 
tetramethyl benzidine (TMB) substrate for 10 minutes. The chromogen reaction 
was stopped by adding 100 |jl of 1 N hydrochloric acid. Plates were then read at a 
wavelength of 450 nm on a microplate reader (Molecular Devices). 
For the NT-4/5 ELISA, the flat bottom wells already pre-coated with 
Neurotrophin-4/5 antibodies were hydrated by 150 |jl of wash buffer for 10 minutes 
at room temperature. Standard control sample for NT-4/5 was diluted serially (1:2) 
from 400-0 pg/ml and plated to two columns of wells (100 [ill well) designated for 
standard curve in every plate. The frozen ELISA samples (described above) were 
thawed on ice, and every sample plated in duplicate for measurement of NT-4/5. 
Following 2 hours incubation at room temperature on a shaker, wells were washed 
in Wash Buffer for 5 times, and treated with solution containing a biotin 
conjugated anti-NT-4/5 monoclonal antibody (the second primary antibody 
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solution; 1:50) for 1 hour. Then, the wells were washed in TEST, treated with 
Streptavidin alkaline phosphatase (1:4000) for 45 minutes, washed again in TBST, 
and treated with Colour Reagent Solution for 10 min. The chromogen reaction was 
stopped by adding 100 |il of Stop Solution. Plates were then read at a wavelength 
of 490 run on a microplate reader (Molecular Devices). 
2.3 Protein analysis (II) - Western blot 
Western Blot analysis was used to investigate the effect of intermittent hypoxia on 
different forms of BDNF (mature monomer, dimmer and pro-BDNF), tPA, plasmin 
and plasminogen. 
2.4.1 Isolation of mouse hippocampus total protein 
Adult male mice (postnatal 42 days) were used for the preparation of protein 
samples. The animals were sacrificed by decapitation. The brains were 
immediately removed and bilateral hippocampi were rapidly dissected and placed 
on dry ice. 100 |al ice-cold Sucrose Lysis buffer containing lOmM Tris base, 
320mM Sucrose, ImM EDTA, 200 \iM PMSF (frozen in isopropanol), 10 |jM 
leupeptin (frozen separately in deionized water), 0.3 |iM aprotinin (frozen 
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separately in 0.0 IM HEPES (pH8)) and 1 |liM pepstatin (frozen separately in 
DMSO) was added to each sample for doing Western Blot analysis. Samples were 
homogenized and then centrifuged at 13,000 x g for 30 min at 4°C. Resulting 
supematants were removed and frozen at -70 °C until analysis. Total protein 
concentration was measured by using a Micro BCA Protein Assay Reagent Kit 
(Pierce Biotechnology, Rockford, USA). In each assay, duplicate wells were 
assigned for each sample. A microplate reader was used to measure signal intensity 
from the wells. 
2.4.2 Western blot Analysis 
For Western analysis of pro-，mature and dimmer form of BDNF, 100 i^g of protein 
sample was used. For tPA，plasmin and plasminogen protein, 50 i^g of protein 
sample was used. The sample proteins were resolved in 12% and 10% SDS-PAGE 
minigel respectively at 80 V for stacking and 120 V for separating gel. Proteins 
were then transferred onto a Nitrocellulose membrane (Bio-rad) soaked with 
Transfer Buffer at llOV for 1 hour. Membrane was blocked by 5% non-fat dry milk 
at 4°C overnight and then with primary antibody at 4°C for 2 hours in 5% non-fat 
dry milk and then probed with the corresponding secondary antibody conjugated 
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with horseradish peroxidase in TBS with 0.2% Tween-20. After stringency washes, 
chemiluminescence signal was developed with ECL Western Blotting Detecting 
Reagents (Amersham) and visualized in X-ray film (Fuji Film). Primary antibodies, 
secondary antibodies and Solution used were listed in Table 2.1 A, Table 2.1 B and 
Table 2.1 C. 
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A 
Primary Antibodies Dilution Company 
Plasminogen (AMPG-9130): ^ ^^^ Santa Cruz 
sc-73465 Biotechnology, Inc. 
Santa Cruz 
tPA (H27B6): sc-59722 1:250 . , , 
Biotechnology, Inc. 
Monoclonal Anti-B-actin Clone … … 
^ 1:2000 Sigma, USA. 
AC-74 
Primary antibodies and their dilutions for Western blot analysis. 
B 
Secondary Antibodies Dilution Company 
Goat Anti-rat IgG-HRP: i.\ooo Santa Cruz 
sc-2006 Biotechnology, Inc. 
Polyclonal Rabbit Anti- Mouse _ _ , ^ . 
1:1000 DakoCytomation 
Immunoglobulins / HRP 
Polyclonal Goat Anti-Rabbit ^ … ^ . 
1:2000 DakoCytomation 
Immunoglobulins/ HRP 
Secondary antibodies and their dilutions for Western blot analysis. 
C 
Solutions Components 
lOx SDS-PAGE running buffer 0.25M Tris base, 1.92M glycine, 1% SDS 
38.6 mM glycine, 48 mM Tris-base, 20% 
Transfer Buffer 
methanol, 0.037% SDS 
Components of solutions used in Western blot analysis. 
Table 2.1 Primary antibodies and secondary antibodies and their dilutions used for 
Western blot analysis are shown in (A) and (B). Components of solutions used in 
Western blot analysis are shown in (C). 
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2.5 Data Analysis 
The data for ELISA were analyzed using Soft-Max computer program associated 
with the microplate reader. The target protein content in each samples were found 
from the optical density values for different known concentrations of the standard, 
which gave a clear standard curve. Values in all samples were normalized by the 
amount of total protein added. The average value for each sample was calculated 
separately before determining the group means. Then, the amounts of target protein 
in different groups were compared using ANOVA with Student's t-test. 
All values described in the present study are expressed as means 士 S.E.M. Unpaired 
student's t test were employed for statistical analysis. The level of significance was 
set at P value = 0.05 which was denoted by *. P< 0.01 is denoted by **. 
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CHAPTER 3 RESULTS 
The hippocampus is widely accepted to play a critical role in the formation of 
memory. Specifically, the CA3 to CAl pathway has been the prototypical pathway 
for the study of neuronal plasticity phenomenon like long-term potentiation (LTP), 
which is at present the best cellular candidate of memory formation. Our laboratory 
recently showed that treatment of intermittent hypoxia results in significant 
reduction of the magnitudes of LTP in CAS to CAl pathway, which may underlie 
the observed memory deficits in OSA models and patients. To elucidate the 
possible mechanisms underlying such observation, I first examined the effect of 
intermittent hypoxia on the membrane properties and excitability of hippocampal 
CAl neurons. Secondly, I determined if the expression levels of hippocampal 
BDNF and a number of related proteins are altered by the intermittent hypoxia 
treatment. 
3.1 Effect of intermittent hypoxia on passive and active 
properties of hippocampal CAl neurons 
3.1.1 Passive Properties 
The passive properties of neurons are their resistive and capacitive characteristics 
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which contribute to their local signaling capacity within the neurons. Here I 
examined the effect of intermittent hypoxia on the resting membrane input 
resistance and the capacitance of hippocampal CAl neurons. 
Membrane Input Resistance 
The input resistance of CAl neurons after normoxia, 3 days, 7 days and 14 days 
intermittent hypoxia treatment was measured, which was determined by the voltage 
response of the neuron to a 20 mV membrane hyperpolarization. Intermittent 
hypoxia treatment decreased the membrane input resistance of these cells 
significantly in a treatment time-dependent manner. Figure 3.1 shows the 
percentage changes in the membrane input resistance of hippocampal CAl neurons 
after normoxia, 3 days, 7 days and 14 days intermittent hypoxia treatment. The 
decrease in membrane resistance were not significant in 3 days IH (138.9 士 3.3 MQ; 
94.2 士 2.4%，n = 76，p > 0.05) when compare with the control (147.42 士 3.82 MQ; 
100.0 士 2.590/0，n = 35). But this decrease became significant in both 7 days IH 
(133.0 士 3.7 MQ; 90.2 士 2.8%，n = 64，p < 0.05) and 14 days IH (128.3 士 5.9 MQ; 
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Figure 3.1 The membrane input resistance of hippocampal CAl neurons after 
normoxia (control), 3 days, 7 days and 14 days intermittent hypoxia (IH) treatment, 
normalized to the control values. Data are expressed as means 士 SE. The number of 
cells in the control, 3 days IH, 7 days IH and 14 days IH groups are 35, 76，64 and 
44 respectively. *： significantly different from control group (p < 0.05). 
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Membrane Capacitance 
Membrane capacitance is the measure of the quantity of charge that must be moved 
across unit area of the membrane to produce unit change in membrane potential. Its 
value is mainly determined by the membrane surface area of the cell. 
The treatment of intermittent hypoxia apparently had no effect on the membrane 
capacitance (Cm) of the CAl neurons. The membrane capacitance of the neurons 
measured in 3 days IH (100.9 士 4.7 i^F), 7 days IH (103.3 士 2.9 i^F), and 14 days IH 
(96.5 士 3.8nF) were at similar level to that of control (99.5 士 4.7nF). The passive 
properties are summarized in Table 3.1. 
membrane resistance (mQ) membrane capacitance (ms) 
Passive Properties 
mean 士 S.E. % control ± % S.E. mean ± S.E. % control ± % S.E. 
control 147.42 ±3.82 100.00 ±4.68 99.50 ±4.66 100.00 ±2.59 
3Days lH 138.91 ±3.29 101.36±3.30 100.85 土 3.33 94.23±2.37 
7 Days IH *132.97±3.73 *103.80±2.83 103.28 ±2.92 90.19 ±2.80 
14 Days IH *128.30± 5.94 *96.94 ±3.90 96.46 ±3.76 87.03 ±4.63 
Table 3.1 Summary of the passive properties of hippocampal CAl cell in control 
and different intermittent hypoxia treatment. Values are means 士 SE and % of 
control ± % SE. Number of cells in control, 3 days IH, 7 days IH and 14 days IH 
are 34，63, 63 and 47 respectively. *: significantly different from control cells (p < 
0.05). 
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3.1.2 Membrane excitability 
The membrane excitability of the CAl neurons after intermittent hypoxia 
treatments was studied by examining their response to direct somatic current 
injection under whole-cell current-clanip recording. Two sets of index were 
measured. First, to investigate the threshold of action potential firing, the amount of 
injected current needed to elicit the first action potential (threshold current) was 
recorded. Second, the input-output relationship of the CAl neurons, in the form of 
current injection - action potential frequency plot, was determined. To better 
elucidate these properties, tests were routinely conducted at a membrane potential 
close to the resting membrane potential (-55mV), and also at a more hyperpolarized 
membrane potential of -70mV. 
Threshold Current 
The threshold holding current is the positive holding current that is needed to elicit 
the first action potential. The higher the holding current needed, the lower the 
excitability of the neuron is. Figure 3.2A shows typical membrane voltages traces 
of hippocampal CAl neurons in response to injection of threshold holding current 
in control, and different days of IH treatments. Figure 3.2B summarizes the pooled 
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data of the threshold current in different groups of neurons. As can be seen, the 
threshold holding current increases as the number of days of intermittent hypoxia 
treatment increases, reaching a significant level in the 14 days IH group. These data 
suggest that a significant decrease in membrane excitability of these neurons occur 
after 14 days of IH treatment. In addition, the number of action potentials elicited 
at the threshold current also decreased significantly in the 14 day IH group, as 
illustrated in Fig. 3.2A and summarized in Fig. 3.2C, a finding which is also 
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Figure 3.2 (A) Typical voltage responses of hippocampal CAl neurons from 
control, 3 day IH, 7 day IH and 14 day IH in response to threshold current injection. 
The changes in the value of holding current with respect to IH treatments and the 
frequency of action potentials elicited at the threshold currents are shown in (B) 
and (C) respectively. Values are means 士 SE. Number of cells in control, 3 days IH, 
7 days IH and 14 days IH are 34, 63，63 and 47 respectively. * denotes p < 0.05 
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Input-Output Relationship of Neuronal Firing 
To further investigate the impact of intermittent hypoxia on the excitability of 
hippocampal CAl neurons, I plotted the input-output relationship of the neurons. 
At a resting potential of -55 mV, the numbers of action potential elicited in 
response to different magnitudes of step current injection - the current-frequency 
relation, was examined in different groups of neurons. The excitation protocol is 
shown in Figure 3.3A and a typical response of CAl neurons is shown in Figure 
3.3B. As expected and shown in Fig. 3.3C, the numbers of action potential 
increased as the step current increased from 20 pA up to 160 pA. Typically, the 
firing of the neurons showed adaptation during the step pulse which lasted 400 ms. 
The current-frequency relationships of these neurons under different IH treatments 
are shown in Fig. 3.4. As can be seen in 3.4A, while the curves representing the 
control and 3 day IH groups are almost identical, neurons from the 7 days and 14 
days IH show reductions in the action potential frequency across the whole range 
of injected currents. The reduction is reflected in both a reduced rising slope, as in 
7 day IH group, as well as a downward shift in the curve, as evident in the 14 day 
IH group. As shown in Fig. 3.4B and 3.4C, whether the magnitude of the injected 
current was small (+40pA) or relatively large (+160pA), the reduction in firing rate 
of the neurons due to hypoxic treatment was evident, and became highly significant 
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after 14 days. 
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Figure 3.3 The depolarization current steps protocol to study the input-output 
relationship of hippocampal CAl neurons is shown in (A). During the experiment, 
the holding current was adjusted until the membrane potential was held at -55 mV. 
Depolarization current steps between -160 pA to +160 pA were applied in 20 pA 
increments. A typical whole cell current-clamp response of a CAl neuron in 
response to the stimulation protocol is shown in (B). The individual responses to 
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Figure 3.3. (A) Frequency-current relationships of hippocampal CAl neurons from 
control and animals undergoing different days of intermittent hypoxia treatment. 
Typical voltage traces in response to +40 pA and +160 pA current injections are 
shown in (B), and summarized in (C). Values are means 士 SE. Number of cells in 
control, 3 days IH, 7 days IH and 14 days IH are 34，63, 63 and 47 respectively. * : 
p < 0.05; **: p < 0.01，compared with control. 
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3.1.3 Action Potential Characteristics 
Action potentials are the signals for neuronal communication, and which are 
generated and governed by a number of voltage-gated ionic conductances in the 
neuronal membrane. A change in the expression and properties of these active 
conductances as a result of hypoxia treatment will alter the characteristics of the 
action potentials and therefore affect the functional capacity of the neurons in 
signaling. Here I performed a detailed quantitative analysis of the action potential 
waveform of hippocampal CAl neurons from mice exposed to the standard 3 days, 
7 days and 14 days intermittent hypoxia treatment protocol. In all groups of 
neurons, the first action potential that was elicited by the threshold current was 
used for analysis. 
Action Potential Amplitude, Width and Area 
Typical waveforms of the action potential generated by CAl neurons from control, 
3 days IH, 7 days IH and 14 days IH groups are shown in Fig. 3.4A. Three major 
parameters were measured: 1) the amplitude, 2) the half-width and 3) the area 
covered by the action potential. It was found that the amplitude of the action 
potential was not changed by hypoxia treatment. The amplitudes in the control, 3 
days IH, 7 days IH and 14 days IH groups were 97.7士 1.5 ms，96.6 士 1.1 ms, 98.2 士 
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0.9 ms and 98.3 士 1.0 ms respectively. However, the duration of the action potential, 
as reflected by the half-width, were significantly increased by intermittent hypoxia 
treatment. In the control group, the half-width of the action potential was 2.06 土 
0.03 ms (100.00 士 1.52o/o，n = 35) n = 35. In the 3 days IH group the value was 
2.18 士 0.04 ms (105.7 士 1.8o/o of control, n = 63; p < 0.05)，and in 7 days IH was 
2.45 士 0.03 ms (118.8 士 l.io/o of control, n = 64; p < 0.01). In 14 days IH group the 
half-width was 2.44 士 0.03 ms (118.2 士 1.2o/o of control, n = 56; p < 0.01). As a 
result of the increase in duration of action potential, the action potential area also 
increased in both 7 days IH (265.9 土 5.1 mV-ms; 126.6 士 1.9o/o of control, n = 64; p 
< 0.01) and 14 days IH (268.4 士 13.0 mV.ms; 127.8 士 4.8o/o of control, n = 56). But 
there was no significant changes in 3 days IH (224.2 士 4.9 mV-ms; 106.8 士 2.2o/o of 
control, n = 64; p > 0.05) when compared with the control (210.0 士 6.1 mV.ms; 
100.0 士 2.9%，n = 64). These data are summarized in Fig. 3.4B. 
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Figure 3.4 (A) Typical traces of the first initiated action potential resulted from 
injection of depolarizing threshold currents in control, 3 days IH, 7 days IH and 14 
days IH groups. (B) The effect of intermittent hypoxia on action potential 
amplitude, half-width and action potential area are shown in (B). Values are means 
士 SE. Number of cells in control, 3 days IH, 7 days IH and 14 days IH groups are 
34, 63，63 and 47 respectively. *: p < 0.05; **: p < 0.01, compared with the control 
data. 
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Rise and Decay Kinetics of Action Potential 
As shown above, intermittent hypoxia induced a clear increase in action potential 
duration. To further understand the nature of this prolongation of action potential, 
the rising and decay kinetics were analyzed. For the rising phase, the time-to-peak 
value increased significantly after 3 days, 7 days and 14 days of hypoxic treatment 
(Fig. 3.5A). This increase in time-to-peak was paralleled by a decrease in the 
maximum rise slope in both the 7 day and 14 day IH group (Fig. 3.5B). Similarly, 
for the decay phase of the action potential, the half decay time also increased 
significantly after 3 days, 7 days and 14 days of hypoxic treatment (Fig. 3.5A), 
which is paralleled by a decrease in the maximum decay slope in both 7 day and 14 
day IH groups (Fig. 3.5B). The raw data of these results are listed in Table 3.2 
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Figure 3.5 (A) The effect of intermittent hypoxia on the time to peak, time to decay 
half-amplitude and time to half-amplitude rise of action potential. (B) The effect of 
intermittent hypoxia on the action potential rise slope and decay slope. Values are 
means ± SE. Number of cells in control, 3 days IH, 7 days IH and 14 days IH are 
34, 63，63 and 47 respectively. * Significantly different from control (p<0.05). ** 
Significant different from control (p<0.01). 
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After-hyperpolarization 
After-hyperpolarization (AHP) is the condition of a neuron immediately following 
an action potential during which the membrane potential becomes more negative 
than the normal resting potential. It is caused by the relatively slow closing of the 
voltage gated K+ channel, and will limit the firing rate of the neuron. The 
magnitude of the AHP after intermittent hypoxia treatments was determined. Fig. 
3.6A shows the representative action potentials from different groups of neurons. 
As the number of days of intermittent hypoxia increased， the 
after-hyperpolarization of the CAl neurons decreased progressively. Statistical 
analysis showed that the decreases were significant in all hypoxia-treated groups: 3 
days IH (3.51 ± 0.22 mV; 60.3 士 6.4o/o, n = 64, p < 0.01)，7 days IH (2.78 士 
0.22mV; 47.8 士 9.6o/o, n = 63, p < 0.01) and 14 days IH (2.36 士 0.36mV; 40.5 士 
15.4%, n = 55, p < 0.01) compared with the control group (5.81 士 0.54mV; 100.0 士 
9.30/0，n = 47) (Figure 3.6B). 
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Figure 3.6 (A) Typical traces of the first action potential resulted from the threshold 
step current depolarization recorded in control, 3 days IH, 7 days IH and 14 days 
IH. The dotted line indicates the resting membrane potential. (B) The effect of 
intermittent hypoxia on the percentage change of AHP measured. Values are 
means 士 SE. Number of cells in control, 3 days IH, 7 days IH and 14 days IH are 
34，63，63 and 47 respectively. *:p< 0.05; **: p < 0.01，compared with control. 
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3.1.4 Other active conductance 
Apart from the waveform of the action potential, I found that intermittent hypoxia 
treatment also affect other active phenomenon including the occurrence of rebound 
spikes and calcium spikes. 
Rebound Spike 
When the CAl neuron is hyperpolarized for a period of time, rebound spike may 
occur upon re-depolarization of the membrane potential. It was found that the 
frequency of occurrence of the rebound spike first changed depending on the days 
of hypoxia treatments. 
Most of these post-inhibitory spikes were recorded in current clamp when the cells 
were hold in -55 mV. Figure 3.7A showed typical examples. In the control group, 9 
out of 34 cells (26.5%) recorded exhibited rebound spike. In 3 days IH group, 
28.1% of cells (18 out of 64) cells recorded shown rebound spike, In 7 days IH 
group, 38.1% (24 out of 63 cells) recorded shown rebound spike. But in 14 days IH 
group, the percentage of cells showing rebound spikes dropped to 9.1% (5 out of 
55 cells) recorded showed rebound spike. 
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Calcium Spike 
Depolarizations with steps of current injected through electrode which results in 
trains of fast, sodium-dependent action potentials that declined progressively in 
amplitude. Following these progressively decreasing action potential are the 
complex calcium spikes which had been well reported and described by other (e.g. 
Callaway et al., 1995; Spruston et al., 1995; Golding et al., 1999). 
In our experiments, calcium spikes were found in some of the CAl hippocampus 
cells recorded after intermittent hypoxia treatment but not in the control cells. The 
typical calcium spikes in prolonged depolarization are shown in Figure 3.7B. 
Notice that there are progressively declines in amplitude in the sodium action 
potential before the occurring of the calcium spike. In 3 days IH group, 1.6% (1 out 
of 64 cells) recorded exhibited calcium spike. In 7 days IH group, 9.5 % (6 out of 
63 cells) showed calcium spike. Like the post-inhibitory rebound spikes, the 
percentage of occurrence of rebound spike decreased in 14 days IH group, which 
has a value of 7.3% (4 out of 55 cells). 
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Figure 3.7 (A) Post-inhibitory rebound spiking by CAl neurons after intermittent 
hypoxia treatment. (B) Typical calcium spikes which have smaller amplitude and 
longer duration when compared to the fast sodium spike (action potentials). 
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Days of intermittent hypoxia treatment 
Active Properties 
control 3 days 旧 7 days IH 14 days IH 
Threshold holding M 98.82 ±4.99 105.00 ±3.51 104.33 ±3.32 **126.79 ± 3.75 
Current (+pA) S 100.00 土 5.05 106.25 ±3.34 105.58 ±3.18 **128.30 ± 2.96 
M 5.70 土 0.52 5.67 土 0.67 5.24 士 0.25 M.34 土 0.26 
Threhold AP frequency 
S 100 ±9.09 99.55 ±6.50 91.96 ±4.83 *76.13±5.93 
M 210.01 ±6.11 224.21 ±4.85 **265.88 土 5.10 **268.37 ± 12.99 
Area(mV. ms) 
S 100.00 ±2.91 106.76 ±2.16 **126.6士1.92 **127.7±4.84 
M 2.06 ±0.03 2.18 ±0.04 **2.45 ± 0.03 **2.44 ± 0.03 
Half-width(ms) 
S 100.00 ±1.66 *105.69±1.79 **118.83 士 1.13 **118.21 ± 1.23 
M 97.65 ±1.48 96.63 土 1.09 98.19 ±0.90 98.27 ±1.04 
Peak amplitude (mV) 
S 100.00 ±1.52 98.96 ±1.13 100.55 ±0.92 100.64 土 1.05 
Time To Half-amplitude M 1.03 ±0.01 1.03 土 0.01 1.04 ±0.00 *1.05 ±0.00 
Rise(ms) S 100.00 士 0.54 99.96 土 0.56 100.20 土 0.38 *101.61 士 0.36 
Time To Decay M 3.10 土 0.03 3.21 ±0.04 **3.48±0.02 **3.47±0.03 
Half-amplitude(ms) S 100.00 ±1.05 *103.65 土 1.20 **112.30 ± 0.70 **111.98 ± 0.80 
M 1.65 土 0.02 1.69 ±0.01 **1.76±0.02 **1.75±0.02 
Time to peak (ms) 
S 100.00 ±2.91 106.76 ±2.16 **126.60 ± 1.92 **127.79 土 4.84 
Maximum decay slope M -51.41 ± 1.00 -50.37 ±1.16 **-44.07 土 0.52 M6.98 土 0.66 
(mV/ms) S 100.00 ±1.95 98.00 ±2.31 **85.73±1.19 *91.40 士 1.41 
Maximum rise M 200.54 ±7.75 198.54 士 5.68 *181.45±5.23 80.05 ± 4.75 
slope(mV/ms) S 1 0 0 . 0 0 ±3.86 99.00 土 2.86 *90.48 土 2.88 **89.79±2.64 
M 5.82 土 0.54 **3.51 ± 0.22 **2.78 ± 0.27 **2.36 ± 0.36 
AHP (mV) 
S 100.00 土 9.32 **60.28±6.38 **47.83 ± 9.55 **40.53 ± 15.44 
Table 3.2 Summary of action potential characteristics of hippocampal CAl neurons 
in control and after different days of intermittent hypoxia treatments. Values are 
means 士 SE (M) and % of control 士 o/o SE (S). Number of cells in control, 3 days 
IH, 7 days IH and 14 days IH are 35，76，64 and 44 respectively. *: p < 0.05; **: p 
<0.01，compared with the control. 
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3.2 Effect of intermittent hypoxia on the expression of 
BDNF and related proteins 
To further elucidate the possible underlying causes of intermittent hypoxia-induced 
impairment in long-term synaptic plasticity in the hippocampus, the expression of 
brain-derived neurotrophic factor (BDNF) and related proteins were determined in 
this second part of study. As mentioned in the Introduction, BDNF was chosen for 
investigation because of its central role in mediating long-term potentiation, both 
the early and late phase. In this study, the expression of BDNF and other known 
neurotrophic factors in the hippocampus after intermittent hypoxia treatments were 
determined. I then investigated the differential expressions of the pro- and mature 
forms of BDNF, and elucidated the expression of the tissue-plasminogen 
activator/plasmin system, which is known to play a critical role in the generation of 
different forms of BDNF. 
3.2.1 Levels of total BDNF, NGF, NT-3 and NT-4/5 
The level of different total neurotrophin expression in mouse hippocampus was 
determined by enzyme linked immunosorbent assay (ELISA) after normoxia, 3 
days, 7 days and 14 days intermittent hypoxia treatment. Our prime interest is on 
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the expression of BDNF, in view of its special role in long-term synaptic plasticity. 
But for comparison purpose, we also studied the levels of three other neurotrophic 
factors in the hippocampus in parallel experiments, namely NT-3, NGF and NT-4/5. 
Intermittent hypoxia downregulates the expression of BDNF. As shown in Fig. 3.8, 
as the number of days of IH increased, the level of total BDNF was progressively 
decreased. Statistical analysis showed that the decreasing trend in hypoxia-treated 
groups: 3 days IH (98.2 士 5.4o/o，n = 8，p > 0.05), 7 days IH (91.6 士�O。/。，n = 7, p 
> 0.05) and 14 days IH (74.20 士 4.35%，n=8，p<0.05) compared with the normoxia 
control group (100.0 士 5.2%，n = 9) (Figure 3.8A). The expression levels of the 
other 3 neurotrophic factors are however different and variable. Only the level of 
total NGF exhibited a pattern similar to that of BDNF, that is, a significantly 
reduced level after 14 days of IH treatment (80.29 士 5.45%，n=9，p<0.01) when 
compared with control (Figure 3.8 C). On the other hand, although the levels of 
total NT-3 seemed to reduce after intermittent hypoxia treatment irrespective of the 
days of IH treatment, none of the differences was statistically significant (Figure 
3.8 B). Interestingly, there was a tendency for the level of total NT-4/5 to increase 
in 3 days and 7 days IH, reaching a statistically significant level in the latter 
(131.48 士 5.920/0，n=8, p<0.01) but followed by a decrease in the 14 days IH group. 
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Therefore, both BDNF and NGF expressions are reduced by IH while the other two 
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Figure 3.8 The levels of total BDNF, NT-3, NGF and NT-4/5 after normoxia, 3 
days, 7 days and 14 days intermittent hypoxia treatment were shown in (A), (B), (C) 
and (D) respectively. All the measurements were done by enzyme linked 
immunosorbent assay (ELISA). Summary of the trends of the various neurotrophic 
factors are shown in E. *: p < 0.05，compared with the control. 
Days of intermittent hypoxia treatment 
Neurotrophins control 3 days IH 7 days IH 14 days IH 
BDNF 100.00 ±5.20 98.15 ±5.36 91.56 ±4.00 *74.20±4.35 
NT-3 100.00 ± 14.31 86.80 ± 10.88 83.86 ± 18.08 90.59 ± 9.54 
NGF 100.00 ±4.15 106.46 ±5.41 89.66 土 3.56 *80.29 土 5.45 
NT-4/5 100.00 ± 11.44 112.43 ±10.18 131.48 ±5.92* 98.89 ± 7.51 
Table 3.3 Summary of the percentage changes in the level of total BDNF, NT-3, 
NGF and NT-4/5 after normoxia, 3 days, 7 days and 14 days intermittent hypoxia 
treatment. *: p < 0.05, compared with the control. 
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3.2.2 Recovery study of the expression of BDNF after IH 
treatment 
To investigate if the effect of IH on decreasing BDNF expression is long lasting or 
transient, we examined its recoverability. To do so, two groups of mice received IH 
treatment for 7 and 14 days respectively, and then they were left for 7 days and 14 
days in normoxia environment. We followed the changes in the expressions of 
BDNF by ELISA during the course of these periods. 
As shown in Figure 3.9A，although the level of BDNF was not significantly 
reduced immediately after 7 days IH hypoxia treatment, its level was reduced 
following 7 days of normoxia period (78.2 土 4.0%，n=7, p<0.05, compared with 
control). Furthermore, the level of BDNF remained significantly low even if the 
mice were allowed 14 days of recovery in normoxia environment (78.6 土 3.4o/o， 
n=6，p<0.01, compared with control). In another set of experiments shown in Fig. 
3.9B, as expected the level of BDNF was significantly reduced after 14 days of IH 
treatment. It was found that after 7 days of recovery period, the level of BDNF 
remained at a similar level (77.5 土 7.7%, n=9, p<0.05，compared with control). 
Furthermore, no further reduction or recovery was observable after 14 days of 
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normaxia treatment (73.5 土 7.2o/o，n=9, p<0.05, compared with control). Together, 
these results suggest that 7 days of IH treatment is sufficient to produce a delayed 
reduction in hippocampal BDNF expression. This effect is long-lasting and not 
recoverable within the time-frame tested, that is, up to 2 weeks. 
The interpretation of the above experiments assumed that the level of BDNF is 
constant in otherwise untreated mice. To confirm that this is the case, we examined 
the BDNF level in the hippocampus from different age groups of mice. As shown 
in Figure 3.9C, there are no significant changes in the total BDNF expression in 6 
weeks, 7 weeks and 8 weeks mice, suggesting that the changes observed in the 
recovery experiments were mainly due to IH treatment. 
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Figure 3.9 The effects of 7 days IH treatment (A) and 14 days IH treatment (B) on 
BDNF expression immediately following the treatment, and also after 7 days and 
14 days of recovery period in normoxia environment. (C) shows that the level of 
BDNF is otherwise constant in 6 to 8 weeks old mice. *: p < 0.05，compared with 
the control (*): p < 0.05; **: p < 0.01，compared with the 7 days IH group. 
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3.2.3 Differential effect of IH on pro-BDNF and mature 
BDNF 
BDNF exists in different forms, which include mature BDNF monomer, mature 
BDNF dimmer and pro-BDNF. As described in Chapter one, pro-BDNF is a 32 
kDa molecule which would undergo cleavage to generate 14 kDa mature BDNF 
monomer by tissue-plasminogen activator (tPA). The mature BDNF monomer is 
non-active. It needs to dimerize itself to a 28 kDa BDNF mature dimmer for 
binding to TrkB receptor in order to function. The ELISA technique used in the 
previous section cannot differentiate different forms of BDNF. This is because the 
binding site of the antibody is located in the preproprotein part of BDNF, which 
means that both the pro and mature forms of BDNF are detected by the ELISA 
protocol. Hence, to clarify the effect of IH on the expression of different forms of 
BDNF, Western blotting analysis was employed in this section. 
Figure 3.1 OA is a typical result of the Western blot experiment. It shows that both 
the monomer and dimmer form of BDNF were reduced after IH treatment while the 
pro BDNF was not affected. These observations were summarized in Fig. 3.1 OB in 
which the results obtained from 9 to 11 samples are pooled together. As can be seen, 
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percentage changes of mBDNF monomer was apparent in all IH-treated groups (3 
days: 64.6 土 2.6%，n=ll, p<0.01; 7 days: 68.0 土 3.6o/o，n=ll, p<0.01 and 14 days: 
76.3 土 4.8o/o，n=ll, all compared with the control). For the dimmer form of BDNF, 
there was a trend of decreased expression as the days of IH treatment increased (3 
days: 88.7 土 2.9o/o，n=9, p > 0.05; 7 days: 90.6 土 3.1%，n=9, p<0.05 and 14 days: 
84.6 土 2.4 %, n=9, p<0.01, all compared with control). On the other hand, there are 
no significant changes in pro-BDNF protein expression in 3 days, 7 days and 14 
days intermittent hypoxia treatment. These data revealed that IH reduced the level 
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3.2.4 Expressions of tissue plasminogen activator, plasmin 
and plasminogen 
The results of the previous experiments suggest a differential effect of IH on pro-
and mature form of BDNF. The cleavage of pro-BDNF to mature BDNF is mainly 
via the action of plasmin, which in turn is generated by tissure plasminogen 
activator (tPA), the enzyme responsible for cleavage of plasminogen to plasmin. To 
further elucidate the possible mechanism of reduced BDNF expression, the present 
experiment examined the expression levels tPA, plasminogen and also that of 
plasmin. Western blot analysis was employed for this study. A typical result is 
shown in Fig. 3.11 A. The level of tPA was reduced, and was dependent on the days 
of IH treatment. Its level was significantly reduced in both 7 days (78.34 土 5.80o/o, 
n=6, p<0.05, compared with control) and 14 days (70.31 土 3.99%，n=6, p<0.01, 
compared with control) groups. The data are summarized in Fig. 3.14B. For both 
plasminogen and plasmin, the expressions were reduced in all IH treated groups. 
For plasminogen, the data for the various groups are - 3 days IH: 75.7 土 l.?�/^, n=6, 
pO.Ol，7 days IH: 79.5 土 2.5o/o，n=6, p<0.05 and 14 days IH: 66.2 土 1.7%，n=6, 
p<0.01, all compared with the control (Fig. 3.11C). For plasmin, the corresponding 
values are - 3 days IH: 78.8 土 2.5o/o，n=6, p<0.05, 7 days IH: 69.5 土 3.5o/o，n=6, 
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p<0.05 and 14 days IH: 76.7 ±.4.8o/o，n=6 p<0.05,lll compared with the control. 
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Figure 3.11 Effect of IH on the expression of the components of the tissue 
plasminogen activator/plasmin system. (A) shows a typical example of Western 
blot analysis, revealing the level of tissure plasminogen activator (tPA) (67 kDa), 
plasminogen (94 kDa), plasmin (32 kDa) and the respective fi -actin (42 kDa) of 
mouse hippocampus. The pooled data for these proteins from multiple animals are 
shown in (B), (C) and (D) respectively. *: p < 0.05; **: p < 0.01, compared with 
the control. 
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Chapter 4 Discussion 
The work of the present thesis was prompted by the finding of our laboratory that 
chronic intermittent hypoxia as a model of obstructive sleep apnea (OSA) causes a 
decrease in the magnitude of long-term potentiation in the mouse hippocampus 
(Xie 2008). This finding provides a cellular basis of the observed memory deficits 
in OSA subjects. Here I want to elucidate the cause(s) underlying such observation. 
In this study I asked two questions. First, does chronic intermittent hypoxia 
treatment affect the membrane excitability of hippocampal CAl neurons? Second, 
is the expression level of BDNF affected by intermittent hypoxia in the 
hippocampus of the mouse? 
4.1 Changes in neuronal excitability of CAl neurons under 
intermittent hypoxia 
During hypoxia or anoxia, the limited oxygen supply would compromise the 
metabolism of the neurons including the process of active transport. In fact, the 
cellular responses to hypoxia within the central nervous system (CNS) of mammals 
have been found to be dependent on multiple factors, which include the severity 
and duration of hypoxia, history of previous hypoxic exposure, CNS region, cell 
121 
type, genetic background, and developmental stage (Haddad et al., 1993; Hand et 
al., 1996; Ma et al., 1997; Gu et al.，2001). 
In the model of intermittent hypoxia that we are interested in, it is possible that 
neurons in the brain will suffer from different degrees of damage, from sublethal 
injury to cell death, depending on the magnitude, duration and periodicity of the 
hypoxia. On the other hand, defensive or adaptive responses may incur to help the 
survival of the neurons. Surprisingly, there have been very few studies focusing on 
the effect of intermittent or cyclic changes of hypoxia on neuronal excitability. 
Given the fact that the hippocampus is a brain area critical for the consolidation of 
memory, the effect of IH on hippocampal neuronal excitability is of particular 
importance. 
The major finding in the present study is that CAl neurons in the hypoxia group 
have a significantly reduced excitability than those of the control group. This is 
reflected by various electrophysiological parameters including increased threshold 
current and also a reduced input-output relationship of action potential firing. That 
this is a real effect caused by intermittent hypoxia is supported by the observation 
that the more prolonged the IH treatment is, the more significant is the reduced 
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neuronal excitability, with the 3 days group showing no difference from the control 
while the 14 days group has a stronger effect than the 7 days group. 
It is essential and useful to understand the cause of this reduced excitability. Both 
the passive and active properties of the neurons may contribute to this. First, it is 
clear from our result that as the number of days of IH treatment increases, the input 
resistance of the CAl neurons decreases (Fig. 3.1). Given that the capacitance, and 
therefore the size, of the neurons remains unchanged, this means that the neuronal 
membrane becomes leakier electrically. Thus, it is expected that a bigger 
depolarizing current would be needed to cause the same membrane depolarization 
to reach the threshold, exactly as reflected by the increased threshold current (Fig. 
3.2)，and the downward shift of the input-output curve from the control (Fig. 3.3). 
This would translate to the in vivo situation that more or bigger synaptic currents, 
and therefore stronger presynapatic activities, are needed to activate these hypoxic 
neurons. However, it seems that a decrease in the input resistance cannot 
completely explain the observed reduction in membrane excitability. First, the 
reductions in input resistance are about 10% and 13% in the 7-day IH and 14-day 
IH groups respectively. However, the increase in threshold current and decrease in 
action potential frequency exceed these magnitudes, especially in the 14 day IH 
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group. Furthermore, it is clear that in the study of the input-output relationship, 
there was not only a downward shift of the curve, but also a reduced rising slope 
(Fig. 3.3). This analysis suggests that in addition to a reduction in input resistance, 
other factors are involved in causing a reduced membrane excitability of the CAl 
neurons, especially when the IH treatment is prolonged. 
Gu et al (2001) have shown that in enzymatically dissociated CAl neurons 
obtained from immature mice undergoing cyclic hypoxia treatment for 4 weeks, the 
current density of voltage-gated Na channels was much reduced leading to smaller 
action potential, and also the need of a bigger stimulation current to evoke the first 
action potential. However, we found in the present study that, in the hypoxic group, 
despite an increased threshold current for eliciting the first action potential, and 
also fewer action potentials in response to current injection, the amplitude of the 
action potential is no different from that of the control. This suggests that the 
current density of the voltage-gated Na channels is not affected by our hypoxia 
paradigm. When compared with that employed by Gu et al (2001), our paradigm is 
"milder" in terms of the lowest oxygen concentration used during hypoxia (10% 
instead of 7.5%) and also the maximum days of treatment (14 days instead of 28 
days), among other differences. Thus, in the absence of a reduced Na current 
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density, reduced neuronal excitability could still occur in CAl neurons after IH 
treatment. 
On the other hand, the reduced excitability could be partly attributable to altered 
channel kinetics under IH treatment. As shown and analysed in Fig. 3.5，the 
duration of the action potential is increased in both the depolarization and 
repolarization phase. This is likely the result of changed channel opening and 
closing properties, or transitions between these states. A more in-depth analysis on 
the channel kinetics is needed to understand the basis of such observation. 
Nevertheless, the slowed kinetics of voltage-gated channels could make the CAl 
neurons less responsive and underlie the decreased firing rate. 
Paradoxically, the magnitude of the fast after-hyperepolarization (AHP) was 
significantly reduced (Fig. 3.6). As the AHP is one of the factors controlling the 
rate of firing of action potential, a reduction in AHP is expected to render the 
neurons more excitable. This is however in contrast to our observation. It is 
possible that a second, slower component of the AHP is more important in 
controlling the firing rate and which has been affected by IH. Unfortunately it is 
not easy to quantify accurately this slow component in current clamp recording as 
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it has a slow kinetics and small amplitude. Nevertheless, as this slow component is 
likely a calcium-activated K conductance, the fact that more calcium may leak into 
the cells after IH treatment, as reflected by the increased calcium spike occurrence 
(Fig. 3.7)，may underlie the decreased action potential firing. To confirm or refute 
such hypothesis, voltage-clamp analysis that allows us to record this current 
directly, will be needed. 
Can we explain the impairment of LTP based on the reduced neuronal excitability 
of the CAl neurons? In principle, one can reason that a reduced neuronal 
excitability represents a compromised metabolic state of the neurons, which may 
have a direct negative effect on LTP production and because LTP is an 
activity-dependent phenomenon. Also, as argued above, the basal synaptic 
transmission of the neurons should be affected, as a stronger synaptic input is 
needed to produce the same degree of post-synaptic activation. However, the 
relationship between the excitability of the neurons per se, or the strength of basal 
synaptic transmission, and the magnitude of LTP is not well understood. 
Nevertheless, one particular aspect between neuronal activity and LTP that has 
received much attention in recent years is the role of activity-dependent release of 
neurotrophic factor, which is the focus of the second part of my study, and 
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discussed in the next section. 
4.2 Intermittent hypoxia-induced changes in BDNF level 
It is now widely accepted that neurotrophins have a crucial role in synaptic 
transmission and plasticity. BDNF is one of the neurotrophins that has been studied 
most extensively in the area of LTP. It is the most abundant neurotrophin in 
hippocampus (Altar et al., 1997; Conner et al., 1997) and its critical role in learning 
and memory has been well established (Lindholm et al., 1994; Lindvall et al., 1994; 
Hall et al., 2000; Alonso et al., 2002; Yamada et al., 2003). To test the possible 
involvement of a lack of BDNF in IH-induced impairment of LTP we examined the 
expression of BDNF after IH treatment. I found that the BDNF was reduced by IH 
treatment (Fig. 3.8). Also, as the number of days of IH increased, the level of total 
BDNF was progressively decreased. As IH may cause apoptotic cell death of 
neurons (Golbart et al., 2003), it can be argued that this effect of IH on BDNF may 
be non-specific. However, the fact that different patterns of expression level were 
found for other known neurotrophic factors (Fig. 3.8) argued against this possibility. 
Interestingly, our study on the recovery of the mice from hypoxia to normoxia 
suggests that 7 days of IH treatment is sufficient to produce a delayed and 
prolonged reduction in hippocampal BDNF expression. When extrapolated to 
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human，it means that after a certain period of intermittent hypoxia, the 
neurocognitive deficit or other BDNF-dependent fimctions would be long-lasting. 
Since BDNF is crucial for the induction and maintenance of LTP, the finding that 
the expression of BDNF is reduced provides an explanation for the observed LTP 
impairment after IH treatment. However, BDNF exist in two main forms: 
pro-BDNF and mature BDNF. Thus, it is important to further distinguish the effect 
of IH on these different forms of BDNF. The fact that it is the mature form of 
BDNF which is being affected most provides further support to our hypothesis. 
Pro-BDNF is known to bind to the p75 neurotrophin receptor with higher affinity 
and facilitate LTD (Woo et al., 2005) while mature BDNF would bind to the Trk B 
receptor with higher affinity and facilitates LTP (Mu et al., 1999; Patterson et al., 
1996). Pro-BDNF has also been shown to induce apoptosis in cultured neurons 
(Mowla et al., 2001). Consistent with the hypothesis that IH induced a lack of 
endogenous BDNF production, our laboratory also found that exogenous 
application of 40ng/ml of BDNF was able to rescue the impaired LTP, bringing its 
magnitude back to the control level (Xie 2008). Furthermore, micro-injection of 
BDNF into the third ventricle of the mouse brain could prevent IH-induced LTP 
reduction (Xie 2008), further supporting the notion that during IH, there is a 
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shortage of BDNF. 
What is the cause of the reduced expression of mature BDNF in the hippocampus 
under IH? There are at least two possibilities: reduced transcription of the BDNF 
gene and/or reduced conversion of pro-BDNF to mature BDNF. It has been 
demonstrated that IH would cause significant decreases in Ser-133 phosphorylated 
CREB (pCREB) without changes in total CREB (Goldbart et al., 2003). pCREB 
would bind to the cAMP-regulating element (CRE) which would increase the 
CREB regulated transcription. It is known that BDNF, NT-3 and NGF expression 
are under CREB regulation while NT-4/5 is not (Riccio et al., 1999; Shaywitz et al., 
1999; Bender et al., 2001; West et al., 2001; Shalizi et al., 2003; McCauslin et al., 
2006). Our finding that the expression of BDNF and NGF are significantly reduced 
in the 14-day IH group, while NT-4/5 is not, is consistent with the action of IH on 
pCREB production. It should be noted that NT-3 expression level also tends to 
decrease under IH although the decrease was not statistically significant. Thus, 
one possible explanation for the decreased BDNF expression under IH is the 
reduced amount ofpCREB, and therefore reduced pCREB-dependent transcription 
of BDNF. 
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One of the important functions of the tPA-plasmin system in CNS is to convert the 
pro-neurotrophin to mature form (Pang et al., 2004). Our results reveal that tPA, 
plasmin and plasminogen expressions are significantly decreased after IH. tPA 
(tissue plasminogen activator) is the protease that cleaves plasminogen to plasmin 
while plasmin is the main protease that cleaves pro-BDNF to mature BDNF. Thus, 
if there is a reduction of tPA, there would be reduced production of plasmin from 
plasminogen, as is found in the present study. In turn, the conversion of pro-BDNF 
to mature BDNF would be reduced leading to a selective reduction of mature 
BDNF. 
4.3 Conclusion 
In this thesis, I aim to seek an explanation for the impaired LTP after the mice are 
exposed to chronic intermittent hypoxia environment mimicking OSA. Two 
seemingly independent effects of IH are observed, namely reduced neuronal 
excitability of CAl neurons and also reduced expression of mature BDNF. Given 
the known critical role of BDNF in hippocampal LTP, the present study provides a 
highly feasible explanation for the impairment in LTP by IH. On the other hand, 
while the reduced membrane excitability may have a direct effect on LTP induction, 
this may also be an alternative or additional cause of reduced BDNF production 
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since it is well known that BDNF expression is activity dependent (Lu et al., 2003), 
as illustrated below: 
obstructive sleep apnea 
i 
intermittent hypoxia/hypoxemia 
Reduced neuronal ^^^^^^^^^ Reduced BDNF expression 
excitability in hippocampus ^ in hippocampus 
\/ 
impaired long-term synaptic plasticity 
I 
Learning and memory deficits 
Overall, the present work points to a critical role of BDNF in mediating IH-induced 
impairment in hippocampal long-term synaptic plasticity. To further substantiate 
the role of BDNF, behavioral correlative studies such as memory tests should be 
performed. Furthermore, the expression level of CREB/pCREB under our hypoxic 
conditions and the degree of neuronal apoptosis should be re-examined. Also, 
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extension of the present and related work to the human condition should be an 
important direction for future studies, 
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